Array and method for detecting spatial information of nucleic acids

A novel nucleic acid array and method provide high-precision intracellular and high-throughput intratissue localization of nucleic acids, addressing the limitations of existing technologies by enabling single-cell and subcellular analysis for spatial detection.

JP2024156848APending Publication Date: 2024-11-06SHENZHEN HUADA GENE INST +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
JP2024126026
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2019-12-06
Filing Date
2024-08-01
Publication Date
2024-11-06

AI Technical Summary

Technical Problem

Existing methods for detecting spatial information of nucleic acids, such as those involving array technology and high-throughput DNA sequencing, struggle with low accuracy and limited spatial resolution, particularly at the single-cell and subcellular levels, due to the constraints of current chip technologies.

Method used

A novel nucleic acid array and method that combines carrier arrays with high-precision intracellular localization and high-throughput intratissue localization, utilizing rolling circle amplification and immobilization sequences to achieve precise spatial detection of nucleic acids, enabling single-cell and subcellular analysis.

Benefits of technology

The solution allows for simultaneous high-precision intracellular and high-throughput intratissue localization of nucleic acids, facilitating applications in cell positioning, intracellular organelle positioning, cell-to-cell interaction, and disease diagnosis with enhanced spatial resolution.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024156848000023
    Figure 2024156848000023
  • Figure 2024156848000024
    Figure 2024156848000024
  • Figure 2024156848000025
    Figure 2024156848000025
Patent Text Reader

Abstract

To provide a method for detecting spatial information of nucleic acids in a sample, as well as a nucleic acid array used in the method and a method for producing the nucleic acid array.SOLUTION: A nucleic acid array for detecting spatial information of a nucleic acid in a sample is provided, which comprises a solid support (e.g., a chip) with multiple kinds of carrier sequences attached to its surface, in which each kind of carrier sequence occupies a different position in the array, said each kind of carrier sequence comprises a plurality of copies of the carrier sequence, and the carrier sequence in the direction from 5' to 3' comprises a positioning sequence and a first immobilization sequence, wherein, the positioning sequence has a unique nucleotide sequence corresponding to the position of the kind of carrier sequence on the array; the first immobilization sequence allows annealing to its complementary nucleotide sequence and initiating an extension reaction.SELECTED DRAWING: None
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to the field of spatial detection of biomolecules. In particular, the present invention provides a method for detecting spatial information of nucleic acids in a sample, a nucleic acid array used in the method, and a method for producing the nucleic acid array. [Background technology]

[0002] The spatial location of cells in tissues significantly affects their functions. To investigate this spatial heterogeneity, it is necessary to quantify and analyze the genome or transcriptome of cells, together with knowledge of their spatial coordinates. However, harvesting small tissue regions, or even single cells, for genomic or transcriptomic analysis is extremely cumbersome, expensive, and imprecise. Therefore, there is a great need to develop methods that can achieve high-throughput detection of spatial information (e.g., nucleic acid location, distribution, and / or expression) on biomolecules (e.g., nucleic acids) at the single-cell level, or even subcellular level. Summary of the Invention

[0003] In order to realize the spatial detection of nucleic acid, the prior art combines array technology with high-throughput DNA sequencing technology to capture nucleic acid in tissue samples, label with positional tags, sequence and analyze the nucleic acid. To obtain a chip that can achieve the above-mentioned objective, the prior art fixes a probe capable of capturing nucleic acid on the chip by spotting or bead-based methods. However, for the droplet spotting method on a flat surface, the size of the active area of ​​the chip obtained by using a microvolume spotting system is at most 200 microns, and the accuracy of cell observation is only 20 cells; the size of the active area of ​​the chip obtained by using a bead-based method together with the diffusion seeding of beads labeled with positional tags is at most 10 microns, and the accuracy of cell observation can only reach the single cell level, and the intracellular level cannot be achieved. The present invention provides a novel nucleic acid array for spatial detection of nucleic acids, a method for preparing the nucleic acid array, and an array-based spatial detection method for nucleic acids that simultaneously realizes high-precision intracellular localization and high-throughput intra-tissue localization, and has important application value. Effect of the Invention

[0004] The present invention provides a novel array for detecting spatial information of nucleic acid and a method for preparing the array. When the nucleic acid array is applied to detect spatial information of nucleic acid, high-precision intracellular localization and high-throughput intracellular localization can be realized simultaneously. The array and the detection method based on the array of the present invention have great application value in cell localization, intracellular localization, intracellular organelle localization, cell-cell interaction, intracellular organelle interaction, molecular pathway research, disease diagnosis, etc. [Brief description of the drawings]

[0005] [Figure 1] FIG. 1 shows an outline of cDNA synthesis after capturing mRNA in Example 2. [Diagram 2]FIG. 1 shows an outline of molecules released from a tip in Example 2. [Diagram 3] FIG. 13 shows the results of detection of 2100 regarding the distribution of cDNA fragments in Example 2. [Figure 4] FIG. 13 shows the matching results between the 25 bp sequence of the first strand obtained by cDNA sequencing and the positioning sequence fq in the capture chip in Example 3. [Diagram 5] FIG. 13 is a graph showing mRNA expression in tissue sections from Example 3. [Figure 6] FIG. 1 shows an outline of the probe primer and carrier sequence contained in the DNB of an exemplary embodiment in Example 4. [Figure 7] FIG. 1 shows an outline of the probes ligated to the chip in Example 4. [Figure 8] FIG. 13 is a diagram showing an outline of cDNA synthesis of captured nucleic acid molecules in Example 5. [Figure 9] FIG. 13 is a diagram showing an outline of molecules released from a chip in Example 5. [Figure 10] FIG. 13 shows the results of detection of 2100 regarding the distribution of cDNA fragments in Example 5. [Figure 11] FIG. 13 shows the matching results between the 20 bp sequence of the first strand obtained by cDNA sequencing and the positioning sequence fq in the capture chip in Example 6. [Figure 12] FIG. 13 is a graph showing mRNA expression in tissue sections from Example 6. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0006] Preparation of nucleic acid arrays In a first aspect, the present invention provides a method for producing a nucleic acid array for detecting spatial information of a nucleic acid in a biological sample, comprising the steps of: (1) providing a plurality of types of carrier sequences, each type of carrier sequence comprising a plurality of copies of a carrier sequence, the carrier sequence comprising, in a 5' to 3' direction, a positioning sequence and a first immobilization sequence; the positioning sequence has a unique nucleotide sequence that corresponds to the position of the carrier sequence of that type in the array; allowing the first immobilized sequence to anneal to its complementary nucleotide sequence and trigger an extension reaction; (2) ligating multiple types of carrier sequences to the surface of a solid support (e.g., a chip); (3) preparing a first primer and performing a primer extension reaction using the carrier sequence as a template such that the first immobilized sequence and the positioning sequence region of the carrier sequence form a double strand, the strand that hybridizes with the carrier sequence being a first nucleic acid molecule, the first nucleic acid molecule comprising, in a 5' to 3' direction, a complementary sequence of the first immobilized sequence and a positioning sequence; the first primer comprising, at its 3' end, a complementary region of the first immobilized sequence, the complementary region of the first immobilized sequence comprising the complementary sequence of the first immobilized sequence or a fragment thereof, and having a free 3' end; The present invention provides a method comprising:

[0007] In certain embodiments, the carrier sequence and the first nucleic acid molecule are single-stranded nucleic acid sequences. In some embodiments, the carrier sequence and the first nucleic acid molecule are single-stranded DNA sequences.

[0008] In some embodiments, in step (3), while performing the extension reaction, the carrier sequence is sequenced to obtain sequence information of the positioning sequence contained in the carrier sequence.

[0009] In some embodiments, in step (1), the plurality of carrier sequences is subjected to the following steps: (i) preparing a plurality of types of carrier sequence templates, the carrier sequence templates including complementary sequences of the carrier sequences; (ii) performing a nucleic acid amplification reaction using each type of carrier sequence template as a template to obtain an amplification product of each type of carrier sequence template, the amplification product comprising multiple copies of the carrier sequence; is provided via.

[0010] In certain embodiments, the amplification is selected from rolling circle amplification (RCA), bridge PCR amplification, multiple strand displacement amplification (MDA), or emulsion PCR amplification.

[0011] In certain embodiments, rolling circle amplification is carried out to obtain DNB formed by concatemer of carrier sequence.In such embodiments, in step (i), a circular template sequence is prepared.In the art, the method for preparing a circular nucleic acid molecule is a conventional method, and can be selected by those skilled in the art according to need.For example, first, a linear nucleic acid template can be obtained, and then the linear nucleic acid template can be circularized by ligase (e.g., DNA ligase).

[0012] In some embodiments, bridge PCR amplification, emulsion PCR amplification, or multiple strand displacement amplification is performed to obtain DNA clusters formed by clonal populations of carrier sequences.

[0013] In some embodiments, the method comprises the following steps: (4) providing a second nucleic acid molecule, the second nucleic acid molecule comprising a capture sequence; the capture sequence is capable of hybridizing to all or a portion of the nucleic acid to be captured and comprises (a) an oligonucleotide sequence capable of capturing mRNA; and / or (b) a random or degenerate oligonucleotide sequence; or (c) a sequence specific to a particular target nucleic acid; the capture sequence has a free 3' end to allow a second nucleic acid molecule to function as an extension primer; (5) ligating the second nucleic acid molecule to the first nucleic acid molecule (e.g., by using a ligase, ligating the second nucleic acid molecule to the first nucleic acid molecule). Further includes:

[0014] In certain embodiments, the second nucleic acid molecule is a single-stranded nucleic acid sequence.In certain embodiments, the second nucleic acid molecule is a single-stranded DNA sequence.In certain embodiments, the second nucleic acid molecule is a single-stranded RNA sequence.

[0015] In certain embodiments, the second nucleic acid molecule comprises, in the 5' to 3' direction, an immobilization region and a capture sequence, and the immobilization region comprises a double-stranded nucleic acid sequence, such as a double-stranded DNA sequence. In some embodiments, the capture sequence contained in the second nucleic acid molecule is a single-stranded nucleic acid sequence, such as a single-stranded DNA sequence or a single-stranded RNA sequence. In such an embodiment, it is easy to understand that the second nucleic acid molecule partially has a double-stranded structure, that is, the immobilization region of the second nucleic acid molecule has a double-stranded structure, and the capture sequence of the second nucleic acid molecule has a single-stranded structure.

[0016] In certain embodiments, the double-stranded nucleic acid sequence has a length of 1 bp to 50 bp, for example, 10 bp to 50 bp, 10 bp to 40 bp, or 10 bp to 30 bp.

[0017] In another embodiment, the method comprises the steps of: (4) providing a second nucleic acid molecule, the second nucleic acid molecule comprising, in a 5' to 3' direction, a complement of the second immobilized sequence and a capture sequence; allowing the complement of the second immobilized sequence to hybridize to its complementary nucleotide sequence; the capture sequence is capable of hybridizing to all or a portion of the nucleic acid to be captured and comprises (a) an oligonucleotide sequence capable of capturing mRNA; and / or (b) a random or degenerate oligonucleotide sequence; or (c) a sequence specific to a particular target nucleic acid; the capture sequence has a free 3' end to allow a second nucleic acid molecule to function as an extension primer; (5) hybridizing the complement of the second immobilized sequence to the second immobilized sequence under conditions that allow annealing, thereby ligating the second nucleic acid molecule to the carrier sequence; (6) Optionally, ligating the first and second nucleic acid molecules, each of which is hybridized to a carrier sequence (e.g., ligating the second nucleic acid molecule to the first nucleic acid molecule by using a ligase). Further includes:

[0018] In such embodiments, each carrier sequence further comprises a second immobilized sequence at its 5' end, which is capable of annealing to its complementary nucleotide sequence, hi some embodiments, the second immobilized sequence is capable of annealing to its complementary nucleotide sequence and triggering an extension reaction (e.g., the second immobilized sequence may be used as a binding site for a bridge PCR primer).

[0019] In certain embodiments, the second nucleic acid molecule is a single-stranded nucleic acid sequence.In certain embodiments, the second nucleic acid molecule is a single-stranded DNA sequence.In certain embodiments, the second nucleic acid molecule is a single-stranded RNA sequence.

[0020] In certain embodiments, the second immobilized sequence is adjacent to the positioning sequence.

[0021] In some embodiments, the second immobilization sequence has a length of 1 bp to 50 bp, for example, 10 bp to 50 bp, 10 bp to 40 bp, 10 bp to 30 bp, or 10 bp to 20 bp.

[0022] In some embodiments, in step (3), the first primer further comprises a unique molecular identifier (UMI) sequence at the 5' end of the region of complementarity of the contained first immobilized sequence, such that the first nucleic acid molecule comprises a UMI sequence at the 5' end of the complement of the contained first immobilized sequence; or in step (4), the second nucleic acid molecule further comprises a UMI sequence, the UMI sequence being located at the 5' end of the capture sequence; A UMI sequence is a nucleotide sequence composed of at least one (e.g., at least two, at least three, at least four, or at least five; e.g., 5-100, 5-50, 10, etc., 5-20) nucleotides N, where each N is independently any one of A, C, G, and T.

[0023] In some embodiments, when the first primer contains a unique molecular identifier (UMI) sequence at the 5' end of the complementary region of the first immobilized sequence contained therein, the first primer may further contain an additional sequence at the 5' end of the UMI sequence.

[0024] In some embodiments, the oligonucleotide sequence capable of capturing mRNA comprises a sequence capable of hybridizing with the polyA tail of mRNA. In certain embodiments, the oligonucleotide sequence capable of capturing mRNA comprises a polyT oligonucleotide sequence. In certain embodiments, the polyT oligonucleotide sequence comprises at least 10 (e.g., at least 20) deoxythymidine residues.

[0025] In certain embodiments, the solid support is a chip.In some embodiments, the solid support can be used as a sequencing platform, such as a sequencing chip.In some embodiments, the solid support is a high-throughput sequencing chip, such as the high-throughput sequencing chip used in Illumina, MGI or Thermo Fisher sequencing platforms.

[0026] In a second aspect, the present invention provides a method for producing a nucleic acid array for detecting spatial information of a nucleic acid in a biological sample, comprising the steps of: (1) providing a plurality of types of carrier sequences, each type of carrier sequence comprising a plurality of copies of a carrier sequence, the carrier sequence comprising, in a 5' to 3' direction, a capture sequence template, a positioning sequence, and a first immobilization sequence; The capture sequence template comprises a complementary sequence of the capture sequence, the capture sequence being capable of hybridizing to all or a portion of the nucleic acid to be captured and comprising (a) an oligonucleotide sequence capable of capturing mRNA; and / or (b) a random or degenerate oligonucleotide sequence; or (c) a sequence specific to a particular target nucleic acid; the positioning sequence has a unique nucleotide sequence that corresponds to the position of the carrier sequence of that type in the array; the first immobilized sequence is allowed to anneal to its complementary nucleotide sequence and trigger an extension reaction; the first immobilized sequence also comprises a cleavage site, and cleavage may be selected from enzymatic cleavage with a nicking enzyme, enzymatic cleavage with a USER enzyme, photocleavage, chemical cleavage, or CRISPR-based cleavage; (2) ligating multiple types of carrier sequences to the surface of a solid support (e.g., a chip); (3) providing a first primer (also referred to as a probe primer), the first primer comprising, in a 5' to 3' direction, a binding region, a cleavage region, and a region of complementarity to a first immobilized sequence, the region of complementarity to the first immobilized sequence comprising a complementary sequence to the first immobilized sequence or a fragment thereof, and having a free 3' end; the binding region comprising a linker capable of ligating to a surface of a solid support; and the cleavage region comprising a cleavage site; performing a primer extension reaction using a first primer as a primer and the carrier sequence as a template, such that the first immobilized sequence, the positioning sequence, and the capture sequence template region of the carrier sequence form a double strand, the strand hybridized with the carrier sequence being a first nucleic acid molecule, the first nucleic acid molecule comprising, in a 5' to 3' direction, the complement of the first immobilized sequence, the complement of the positioning sequence, and the capture sequence; the first nucleic acid molecule may also be referred to as a capture probe; (4) ligating a first primer to the surface of a solid support, wherein steps (3) and (4) are performed in any order; (5) optionally performing cleavage at a cleavage site contained in the first immobilized sequence of the carrier sequence to digest the carrier sequence so that the extension product of step (3) is separated from the template (i.e., the carrier sequence) for forming the extension product, such that the first nucleic acid molecule (capture probe) is ligated to the surface of a solid support (e.g., a chip); The present invention provides a method comprising:

[0027] The capture probe (i.e., the first nucleic acid molecule) is obtained by performing primer extension using the carrier sequence as a template, so that the capture probe contains a complement of a unique positioning sequence that corresponds to the position of that type of capture probe (that type of carrier sequence) in the array, and a capture sequence that can hybridize with all or part of the nucleic acid molecule to be captured. The position of that type of capture probe in the array can be determined by analyzing the complement of the positioning sequence.

[0028] In this context, the expression "each type of carrier array" refers to carrier arrays that include the same positioning sequence.

[0029] In some embodiments, in step (1), the plurality of carrier sequences is subjected to the following steps: (i) preparing a plurality of types of carrier sequence templates, the carrier sequence templates including complementary sequences of the carrier sequences; (ii) performing a nucleic acid amplification reaction using each type of carrier sequence template as a template to obtain an amplification product of each type of carrier sequence template, the amplification product comprising multiple copies of the carrier sequence; is provided via.

[0030] In certain embodiments, the amplification is selected from rolling circle amplification (RCA), bridge PCR amplification, multiple strand displacement amplification (MDA), or emulsion PCR amplification.

[0031] In certain embodiments, rolling circle amplification is carried out to obtain DNB formed by concatemer of carrier sequence.In such embodiments, in step (i), a circular template sequence is prepared.In the art, the method for preparing a circular nucleic acid molecule is a conventional method, and can be selected by those skilled in the art according to need.For example, first, a linear nucleic acid template can be obtained, and then the linear nucleic acid template can be circularized by ligase (e.g., DNA ligase).

[0032] In certain embodiments, each type of carrier sequence is a DNB formed by a concatemer of multiple copies of the carrier sequence.

[0033] In some embodiments, step (1) comprises the steps of: (1a) providing a circular nucleic acid template, the circular nucleic acid template comprising one type of carrier sequence template, the carrier sequence template comprising a complementary sequence of the carrier sequence, i.e., the carrier sequence template comprises, in a 5' to 3' direction, a complement of a first immobilization sequence, a complement of a positioning sequence, and a capture sequence; (1b) performing rolling circle amplification (RCA) using the circular nucleic acid template as a template to obtain DNBs (DNA nanoballs) formed by concatemers of carrier sequences; Includes.

[0034] In some embodiments, bridge PCR amplification, emulsion PCR amplification, or multiple strand displacement amplification is performed to obtain DNA clusters formed by clonal populations of carrier sequences.

[0035] In some embodiments, the cleavage site contained in the first immobilization sequence is a cleavage site for a nicking enzyme. In some embodiments, the nicking enzyme is selected from USER, BamHI, BmtI, etc. In certain exemplary embodiments, the cleavage site is shown in SEQ ID NO: 14.

[0036] In some embodiments, the first immobilized sequence further comprises a hybridization region for a sequencing primer and / or a hybridization region for an amplification primer; the hybridization region for the sequencing primer allows for annealing to the sequencing primer and triggering a sequencing reaction, and the hybridization region for the amplification primer allows for annealing to the amplification primer and triggering an extension reaction and an amplification reaction.

[0037] In some embodiments, the first immobilization sequence has a length of more than 1 bp, such as more than 10 bp or more than 20 bp. In some embodiments, the first immobilization sequence has a length of 20-100 bp, such as 20-80 bp.

[0038] In some embodiments, the positioning sequence has a length of more than 1 bp, such as more than 10 bp, In some embodiments, the positioning sequence has a length of 10-100 bp, such as 10-50 bp, such as 10-30 bp, such as 20 bp.

[0039] In some embodiments, the oligonucleotide sequence capable of capturing mRNA comprises a sequence capable of hybridizing with the polyA tail of mRNA. In certain embodiments, the oligonucleotide sequence capable of capturing mRNA comprises a polyT oligonucleotide sequence. In certain embodiments, the polyT oligonucleotide sequence comprises at least 10 (e.g., at least 20) deoxythymidine residues.

[0040] In some embodiments, the capture sequence has a length of more than 1 bp, hi some embodiments, the capture sequence has a length of 1-100 bp, such as 10-50 bp, such as 10-30 bp.

[0041] In some embodiments, the carrier sequence further comprises a complement of a UMI sequence (also referred to as a probe tag region) located downstream of the capture sequence template and upstream of the first immobilized sequence, the complement of the UMI sequence being complementary to the UMI sequence, the UMI sequence being a nucleotide sequence comprised of at least one (e.g., at least two, at least three, at least four, or at least five; e.g., 5-100, 5-50, 10, etc., 5-20) nucleotides N, each N being independently any one of A, C, G, and T. In some embodiments, the complement of the UMI sequence is located between the positioning sequence and the capture sequence template. In other embodiments, the complement of the UMI sequence is located between the first immobilized sequence and the positioning sequence. In such embodiments, in step (3), when a primer extension reaction is performed using the carrier sequence as a template, the first nucleic acid molecule / capture probe that hybridizes to the carrier sequence will correspondingly contain a UMI sequence (also referred to as a probe tag).

[0042] In some embodiments, to obtain the above UMI sequence or its complementary sequence, the template sequence of the carrier sequence (i.e., the template of the carrier sequence) contains a UMI sequence template at the corresponding position, and the UMI sequence template is a sequence composed of modified bases, and the modified base can be complementary paired with various primary bases (e.g., C, G, A, T, U) by hydrogen bonding; for example, the modified base can be inosine, which can be complementary paired with bases A, C, and U. Without being bound by any theory, it is considered that when the template of the carrier sequence contains a UMI sequence template, the bases capable of complementary pairing with the UMI sequence template are randomly combined in the rolling circle amplification process each time amplification is performed, so that each round of amplification product has a randomly formed unique UMI sequence, thereby distinguishing each round of amplification product. Thus, for example, copy number can be quantified for different nucleic acid molecules that are captured. In some embodiments, the UMI sequence template includes a plurality (e.g., at least 10, such as 10-100) inosines. In some embodiments, the UMI sequence template has a length greater than 1 bp. In some embodiments, the UMI sequence template has a length greater than 5 bp. In some embodiments, the UMI sequence template has a length of 5-100 bp, such as 5-50 bp, such as 5-20 bp, such as 5-15 bp, such as 10 bp.

[0043] In certain embodiments, the solid support is a chip. In some embodiments, the solid support can be used as a sequencing platform. In some embodiments, the solid support is a sequencing chip (MGI), such as the sequencing chip of BGISEQ-500 platform. In some embodiments, the solid support is a high-density array chip, which can be obtained by the method described in, for example, Chinese Patent No. 103180496.

[0044] Carrier sequences (e.g., DNB) can be ligated to the surface of the solid support by any suitable method known in the art, in certain embodiments, non-limiting examples of which include nucleic acid hybridization, biotin-streptavidin binding, sulfhydryl binding, photoactivated binding, covalent binding, antibody-antigen binding, physical confinement by hydrogel or other porous polymeric materials, and the like, or any combination thereof.

[0045] In some embodiments, the solid support is selected from the following materials: glass, silicon, polylysine coated material, nitrocellulose, polystyrene, cyclic olefin copolymer (COC), cyclic olefin polymer (COP), polypropylene, polyethylene, or polycarbonate, etc.

[0046] In some embodiments, in step (3), the carrier sequence (e.g., the contained positioning sequence) is sequenced while performing the primer extension reaction to obtain sequence information of the positioning sequence contained in the carrier sequence.

[0047] In some embodiments, the step (3) before further comprises sequencing the carrier sequence (e.g., the positioning sequence contained). In some embodiments, after the sequencing is completed, washing is performed to remove the dNTPs added to the synthetic strand for sequencing.

[0048] In certain embodiments, the linker is a linking group capable of coupling with an activated group (e.g., NH2). In such embodiments, the surface of the solid support is modified with an activated group (e.g., NH2). In some embodiments, the linker comprises -SH, -DBCO, -NHS, etc. In certain exemplary embodiments, the linker is DBCO and Azido-dPEG® 8-NHS ester is attached to the surface of the solid support. [ka] In some embodiments, the cleavage site contained in the cleavage region of the first primer is a site where controlled cleavage can be performed by chemical, enzymatic, or photochemical methods. In certain embodiments, the cleavage site is an enzyme cleavage site. In some embodiments, the enzyme site is the enzyme site (UUU) of the USER enzyme.

[0049] In some embodiments, the cleavage region of the first primer is different from the cleavage site contained in the first immobilized sequence of the carrier sequence.

[0050] In certain embodiments, the amplification comprises PCR.

[0051] Nucleic Acid Arrays and Kits In a third aspect, the present invention provides a nucleic acid array for detecting spatial information of nucleic acids in a sample, comprising a solid support (e.g., a chip) having a plurality of types of carrier sequences attached to a surface, each type of carrier sequence occupying a different position in the array, each type of carrier sequence comprising a plurality of copies of the carrier sequence, the carrier sequence comprising, in a 5' to 3' direction, a positioning sequence, and a first immobilization sequence; the positioning sequence has a unique nucleotide sequence that corresponds to the position of the carrier sequence of that type in the array; The first immobilized sequence is allowed to anneal to its complementary nucleotide sequence and trigger an extension reaction. A nucleic acid array is provided.

[0052] In certain embodiments, each type of carrier sequence (i.e., carrier sequences containing the same positioning sequences) occupies an area (i.e., an active area) on the surface of the solid support that is less than 1 micron in diameter, e.g., about 900 nanometers, about 800 nanometers, about 700 nanometers, about 600 nanometers, or about 500 nanometers.

[0053] In some embodiments, the nucleic acid array further comprises a first nucleic acid molecule, which comprises, in the 5' to 3' direction, the complement of the first immobilized sequence and the complement of the positioning sequence, and hybridizes with the first immobilized sequence and the positioning sequence of the carrier sequence to form a double-stranded structure. It is easy to understand that in the first nucleic acid molecule, only the complement of the first immobilized sequence and the complement of the positioning sequence are complementary to the corresponding sequence of the carrier sequence, thereby forming a double strand, so that the double strand formed by the first immobilized sequence and the carrier sequence is an incomplete double strand, i.e., a partial double stranded structure.

[0054] In certain embodiments, each copy of each type of carrier sequence has a first nucleic acid molecule hybridized to it.

[0055] In certain embodiments, the carrier sequence and the first nucleic acid molecule are single-stranded nucleic acid sequences. In some embodiments, the carrier sequence and the first nucleic acid molecule are single-stranded DNA sequences.

[0056] In some embodiments, the nucleic acid array further comprises a second nucleic acid molecule, which is ligated to the first nucleic acid molecule and thereby immobilized to the nucleic acid array, wherein the second nucleic acid molecule comprises a capture sequence; The capture sequence is capable of hybridizing to all or a portion of the nucleic acid to be captured and comprises (a) an oligonucleotide sequence capable of capturing mRNA; and / or (b) a random or degenerate oligonucleotide sequence; or (c) a sequence specific to a particular target nucleic acid; the capture sequence has a free 3' end to allow a second nucleic acid molecule to function as an extension primer.

[0057] In certain embodiments, each first nucleic acid molecule is ligated to a second nucleic acid molecule.

[0058] In some embodiments, the 5' end of the second nucleic acid molecule is ligated to the 3' end of the first nucleic acid molecule.

[0059] In other embodiments, the nucleic acid array further comprises a second nucleic acid molecule, where the second nucleic acid is hybridized to the carrier sequence and thereby immobilized to the nucleic acid array.

[0060] In such embodiments, each carrier sequence further comprises at its 5' end a second immobilized sequence capable of annealing to its complementary nucleotide sequence; the second nucleic acid molecule comprises, in a 5' to 3' direction, a complement of the second immobilized sequence and a capture sequence; the complement of the second immobilized sequence hybridizes to the second immobilized sequence of the carrier sequence to form a duplex; The capture sequence is capable of hybridizing to all or a portion of the nucleic acid to be captured and comprises (a) an oligonucleotide sequence capable of capturing mRNA; and / or (b) a random or degenerate oligonucleotide sequence; or (c) a sequence specific to a particular target nucleic acid; the capture sequence has a free 3' end to allow a second nucleic acid molecule to function as an extension primer.

[0061] In certain embodiments, each copy of each type of carrier sequence includes a second nucleic acid molecule hybridized to it.

[0062] In some embodiments, the second immobilized sequence allows for annealing to its complementary nucleotide sequence and triggering an extension reaction (e.g., the second immobilized sequence can be used as a binding site for a bridge PCR primer).

[0063] In certain embodiments, the second immobilized sequence is adjacent to the positioning sequence.

[0064] In certain embodiments, the second nucleic acid molecule has a 5' end modification, hi certain embodiments, the modification is a phosphorylation or a biotin modification.

[0065] In certain embodiments, the second nucleic acid molecule is a single-stranded nucleic acid sequence.In certain embodiments, the second nucleic acid molecule is a single-stranded DNA sequence.In certain embodiments, the second nucleic acid molecule is a single-stranded RNA sequence.

[0066] In some embodiments, the multiple copies of the carrier sequence are amplification products formed by amplification of a complementary sequence of the carrier sequence as a template, the amplification being selected from rolling circle amplification (RCA), bridge PCR amplification, multiple strand displacement amplification (MDA), or emulsion PCR amplification.

[0067] In certain embodiments, the multiple copies of the carrier sequence are DNBs formed by concatemerization of the carrier sequence. In certain embodiments, the multiple copies of the carrier sequence are DNBs formed by rolling circle amplification using the complementary sequence of the carrier sequence as a template.

[0068] In certain embodiments, the multiple copies of the carrier sequence are DNA clusters formed by a clonal population of the carrier sequence.

[0069] In some embodiments, the multiple copies of the carrier sequence are DNA clusters formed by bridge PCR amplification using the complementary sequence of the carrier sequence as a template.

[0070] In some embodiments, the multiple copies of the carrier sequence are DNA clusters formed by emulsion PCR amplification of complementary sequences of the carrier sequence as a template.

[0071] In some embodiments, the multiple copies of the carrier sequence are DNA clusters formed by multiple strand displacement amplification by using complementary sequences of the carrier sequence as templates.

[0072] In some embodiments, the first nucleic acid molecule further comprises a unique molecular identifier (UMI) sequence, where the UMI sequence is located at the 5' end of the complement of the first immobilized sequence; or the second nucleic acid molecule further comprises a UMI sequence, where the UMI sequence is located at the 5' end of the capture sequence; A UMI sequence is a nucleotide sequence composed of at least one (e.g., at least two, at least three, at least four, or at least five; e.g., 5-100, 5-50, 10, etc., 5-20) nucleotides N, where each N is independently any one of A, C, G, and T.

[0073] In certain embodiments, the solid support is a chip.In some embodiments, the solid support can be used as a sequencing platform, such as a sequencing chip.In some embodiments, the solid support is a high-throughput sequencing chip, such as the high-throughput sequencing chip used in Illumina, MGI or Thermo Fisher sequencing platforms.

[0074] In some embodiments, the oligonucleotide sequence capable of capturing mRNA comprises a sequence capable of hybridizing with the polyA tail of mRNA. In certain embodiments, the oligonucleotide sequence capable of capturing mRNA comprises a polyT oligonucleotide sequence. In certain embodiments, the polyT oligonucleotide sequence comprises at least 10 (e.g., at least 20) deoxythymidine residues.

[0075] In some embodiments, the positioning sequence has a length of more than 1 nt, such as more than 5 nt. In some embodiments, the positioning sequence has a length of 5-50 nt, such as 10-50 nt, 10-30 nt, or 20-30 nt. In some embodiments, the lengths of the positioning sequences contained in the different types of carrier sequences may be the same or different.

[0076] In some embodiments, the capture sequence has a length of more than 1 nt, hi certain embodiments, the capture sequence has a length of 1-100 nt, such as 1-50 nt, such as 10-30 nt.

[0077] In some embodiments, the first immobilization sequence has a length of more than 1 nt, such as more than 10 nt. In some embodiments, the first immobilization sequence has a length of 10-200 nt. In some embodiments, the first immobilization sequence has a length of 20-100 nt, such as 20-50 nt.

[0078] In some embodiments, the second immobilization sequence has a length of more than 1 nt, such as more than 10 nt, In some embodiments, the second immobilization sequence has a length of 10-200 nt, e.g., 10-100 nt, 10-50 nt, 10-30 nt, or 10-20 nt.

[0079] In a fourth aspect, the present invention provides a kit for detecting spatial information of a nucleic acid in a sample, comprising: (i) a nucleic acid array according to the third aspect, not comprising a second nucleic acid molecule; and (ii) a second nucleic acid molecule comprising, in a 5' to 3' direction, an immobilization region and a capture sequence; The capture sequence is capable of hybridizing to all or a portion of the nucleic acid to be captured and comprises: (a) an oligonucleotide sequence capable of capturing mRNA; and / or (b) a random or degenerate oligonucleotide sequence; or (c) a sequence specific to a particular target nucleic acid; and the capture sequence has a free 3' end to allow a second nucleic acid molecule to function as an extension primer. Provide a kit.

[0080] In some embodiments, the kit includes: (i) a solid support (e.g., a chip) having multiple types of carrier sequences attached to a surface thereof, each type of carrier sequence occupying a different location in the array, each type of carrier sequence comprising multiple copies of the carrier sequence, the carrier sequence comprising, in a 5' to 3' direction, a positioning sequence, and a first immobilization sequence; the positioning sequence has a unique nucleotide sequence that corresponds to the position of the carrier sequence of that type in the array; allowing the first immobilized sequence to anneal to its complementary nucleotide sequence and trigger an extension reaction; The nucleic acid array also includes a first nucleic acid molecule that includes, in a 5' to 3' direction, a complement of the first immobilized sequence and a complement of the positioning sequence, and that hybridizes to the first immobilized sequence and the positioning sequence of the carrier sequence to form a duplex. Nucleic acid arrays; and (ii) the immobilization region comprises a second nucleic acid molecule comprising a double-stranded DNA sequence;

[0081] It is easy to understand that a ligase can be used to ligate the second nucleic acid molecule described in (ii) to the first nucleic acid molecule contained in the nucleic acid array described in (i). Thus, in certain embodiments, the kit further comprises a ligase.

[0082] In other embodiments, the kit includes: (i) a solid support (e.g., a chip) having multiple types of carrier sequences attached to its surface, each type of carrier sequence occupying a different location in the array, each type of carrier sequence comprising multiple copies of the carrier sequence, the carrier sequence comprising, in a 5' to 3' direction, a second immobilization sequence, a positioning sequence, and a first immobilization sequence; allowing the second immobilized sequence to anneal to its complementary nucleotide sequence; the positioning sequence has a unique nucleotide sequence that corresponds to the position of the carrier sequence of that type in the array; allowing the first immobilized sequence to anneal to its complementary nucleotide sequence and trigger an extension reaction; The nucleic acid array also includes a first nucleic acid molecule that includes, in a 5' to 3' direction, a complement of the first immobilized sequence and a complement of the positioning sequence, and that hybridizes to the first immobilized sequence and the positioning sequence of the carrier sequence to form a duplex. Nucleic acid arrays; and (ii) a second nucleic acid molecule, the immobilization region of which comprises the complement of the second immobilization sequence; Includes.

[0083] In certain embodiments, the second immobilized sequence is adjacent to the positioning sequence.

[0084] It is easy to understand that under conditions that allow annealing, the second nucleic acid molecule described in (ii) can hybridize with the complementary region of the carrier sequence contained in the nucleic acid array described in (i), and thus the second nucleic acid molecule can be ligated to the first nucleic acid molecule by using a ligase.Therefore, in certain embodiments, the kit further comprises a ligase.

[0085] In another aspect, the present invention also relates to the use of a nucleic acid array according to the third aspect, or a kit according to the fourth aspect, for detecting spatial information of nucleic acids in a sample, or the use thereof in the manufacture of a detection reagent for detecting spatial information of nucleic acids in a sample.

[0086] In some embodiments, the spatial information of the nucleic acid includes the location, distribution, and / or expression of the nucleic acid.

[0087] In certain embodiments, the sample is a tissue sample, such as a tissue sample containing cells. In some embodiments, the sample is a tissue section. In certain embodiments, the tissue section is prepared from fixed tissue, such as formalin-fixed paraffin-embedded (FFPE) tissue, or flash-frozen tissue.

[0088] In a fifth aspect, the present invention also provides a nucleic acid array for detecting spatial information of nucleic acids in a sample, comprising a solid support (e.g., a chip) having a plurality of types of carrier sequences attached to a surface, each type of carrier sequence occupying a different position in the array, each type of carrier sequence comprising a plurality of copies of the carrier sequence, the carrier sequence comprising, in a 5' to 3' direction, a capture sequence template, a positioning sequence, and a first immobilization sequence; The capture sequence template comprises a complementary sequence of the capture sequence, the capture sequence being capable of hybridizing to all or a portion of the nucleic acid to be captured and comprising (a) an oligonucleotide sequence capable of capturing mRNA; and / or (b) a random or degenerate oligonucleotide sequence; or (c) a sequence specific to a particular target nucleic acid; the positioning sequence has a unique nucleotide sequence that corresponds to the position of the carrier sequence of that type in the array; The first immobilized sequence allows for annealing to its complementary nucleotide sequence and triggering an extension reaction, and the first immobilized sequence also includes a cleavage site, and the cleavage may be selected from enzymatic cleavage with a nicking enzyme, enzymatic cleavage with a USER enzyme, photocleavage, chemical cleavage, or CRISPR-based cleavage. The nucleic acid array also includes a first nucleic acid molecule (also referred to as a capture probe), the first nucleic acid molecule including, in a 5' to 3' direction, a binding region, a cleavage region, and a region of complementarity to a carrier sequence; the binding region comprises a linker capable of ligating to the surface of a solid support; the cleavage region comprises a cleavage site; the complementary region of the carrier sequence includes, in a 5' to 3' direction, a sequence that can be complementary to the carrier sequence, including a complement of the first immobilized sequence, a complement of the positioning sequence, and a capture sequence; the capture sequence has a free 3' end to allow the first nucleic acid molecule to function as an extension primer; The complementary region of the first nucleic acid molecule to the carrier sequence hybridizes with the carrier sequence to form a duplex. It also relates to nucleic acid arrays.

[0089] In certain embodiments, the carrier sequence and the first nucleic acid molecule are single-stranded nucleic acid sequences. In some embodiments, the carrier sequence and the first nucleic acid molecule are single-stranded DNA sequences.

[0090] In certain embodiments, each copy of each type of carrier sequence has a first nucleic acid molecule, as described above, hybridized to it.

[0091] In some embodiments, the linker of the first nucleic acid molecule is a linking group capable of coupling with an activated group (e.g., NH2), and the surface of the solid support is modified with an activated group (e.g., NH2). In certain embodiments, the linker comprises -SH, -DBCO, or -NHS. In some embodiments, the linker is [ka] and [ka] is attached to the surface of the solid support.

[0092] In some embodiments, the cleavage site contained in the first immobilization sequence is a cleavage site for a nicking enzyme. In some embodiments, the nicking enzyme is selected from USER, BamHI, BmtI, etc. In certain exemplary embodiments, the cleavage site is shown in SEQ ID NO: 14.

[0093] In some embodiments, the cleavage site contained in the cleavage region of the first nucleic acid molecule is a site where controlled cleavage can be performed by chemical, enzymatic, or photochemical methods. In certain embodiments, the cleavage site is an enzymatic cleavage site. In some embodiments, the cleavage site is the cleavage site (UUU) of the USER enzyme.

[0094] In some embodiments, the cleavage region of the first nucleic acid molecule is different from the cleavage site contained in the first immobilized sequence of the carrier sequence.

[0095] In certain embodiments, the nucleic acid array is prepared by the method described in the second aspect.

[0096] In some embodiments, the multiple copies of the carrier sequence are amplification products formed by amplification of a complementary sequence of the carrier sequence as a template, the amplification being selected from rolling circle amplification (RCA), bridge PCR amplification, multiple strand displacement amplification (MDA), or emulsion PCR amplification.

[0097] In certain embodiments, the multiple copies of the carrier sequence are DNBs formed by concatemerization of the carrier sequence. In certain embodiments, the multiple copies of the carrier sequence are DNBs formed by rolling circle amplification using the complementary sequence of the carrier sequence as a template.

[0098] In certain embodiments, the multiple copies of the carrier sequence are DNA clusters formed by a clonal population of the carrier sequence.

[0099] In some embodiments, the multiple copies of the carrier sequence are DNA clusters formed by bridge PCR amplification using the complementary sequence of the carrier sequence as a template.

[0100] In some embodiments, the multiple copies of the carrier sequence are DNA clusters formed by emulsion PCR amplification of complementary sequences of the carrier sequence as a template.

[0101] In some embodiments, the multiple copies of the carrier sequence are DNA clusters formed by multiple strand displacement amplification by using complementary sequences of the carrier sequence as templates.

[0102] In some embodiments, the carrier sequence further comprises a complement of a UMI sequence disposed downstream of the capture sequence template and upstream of the first immobilized sequence, where the complement of the UMI sequence is complementary to the UMI sequence, where the UMI sequence is a nucleotide sequence comprised of at least one (e.g., at least two, at least three, at least four, or at least five; e.g., between 5 and 100, between 5 and 50, between 10, etc., between 5 and 20) nucleotides N, where each N is independently any one of A, C, G, and T; The region of complementarity of the carrier sequence of the first nucleic acid molecule further comprises a UMI sequence located upstream of the capture sequence and downstream of the complement of the first immobilized sequence.

[0103] In some embodiments, the complement of the UMI sequence is located between the positioning sequence and the capture sequence template, or between the first immobilized sequence and the positioning sequence.

[0104] In some embodiments, each copy of each type of carrier sequence (i.e., carrier sequences that contain the same positioning sequence) has a different complement of the UMI sequence. Correspondingly, the first nucleic acid molecule (capture probe) hybridized to each copy of the carrier sequence also has a different UMI sequence.

[0105] In some embodiments, the carrier sequence is removed from the nucleic acid array via a cleavage site contained in the first immobilized sequence of the carrier sequence. In such embodiments, the nucleic acid array comprises a solid support (e.g., a chip) with a plurality of types of capture probes (first nucleic acid molecules) attached to the surface, each type of capture probe (first nucleic acid molecule) occupies a different position in the array, the capture probes (first nucleic acid molecules) are oriented to have a free 3' end to enable them to function as extension primers, and each type of capture probe (first nucleic acid molecule) comprises, in the 5' to 3' direction, a binding region, a cleavage region, a complement of the positioning sequence, and a capture sequence; The binding region comprises a linker capable of ligating to the surface of a solid support; the cleavage region comprises a cleavage site; the positioning sequence corresponds to the location of that type of capture probe in the array; The capture sequence is capable of hybridizing to all or a portion of the nucleic acid to be captured and includes (1a) an oligonucleotide sequence capable of capturing mRNA; and / or (1b) a random or degenerate oligonucleotide sequence; or (c) a sequence specific to a particular target nucleic acid.

[0106] In some embodiments, each capture probe of each type of capture probe (i.e., capture probes that contain the same positioning sequence / complement of the positioning sequence) has a different UMI sequence, and the UMI sequence is located upstream of the capture sequence and downstream of the cleavage region. In some embodiments, the UMI sequence is located at the 5' end of the capture sequence, e.g., between the capture sequence and the complement of the positioning sequence. In other embodiments, the UMI sequence is located at the 5' end of the complement of the positioning sequence, e.g., between the cleavage region and the complement of the positioning sequence.

[0107] In some embodiments, each type of carrier sequence (i.e., carrier sequences that include the same positioning sequence) or each type of capture probe (i.e., capture probes that include the same positioning sequence / complement of the positioning sequence) occupies an area (i.e., active area) on the surface of the solid support that is less than 1 micrometer in diameter, for example, about 900 nanometers, about 800 nanometers, about 700 nanometers, about 600 nanometers, or about 500 nanometers. In certain embodiments, each type of carrier sequence or each type of capture probe has an active area that is about 500 nanometers in diameter.

[0108] In certain embodiments, the solid support is a chip. In some embodiments, the solid support can be used as a sequencing platform. In some embodiments, the solid support is a sequencing chip (MGI), such as the BGISEQ-500 platform. In some embodiments, the solid support is a high-density array chip, which can be obtained by the method described in, for example, Chinese Patent No. 103180496.

[0109] In some embodiments, the first immobilization sequence has a length of more than 1 bp, such as more than 10 bp or more than 20 bp. In some embodiments, the first immobilization sequence has a length of 20-100 bp, such as 20-80 bp.

[0110] In some embodiments, the positioning sequence has a length of more than 1 bp, such as more than 10 bp, In some embodiments, the positioning sequence has a length of 10-100 bp, such as 10-50 bp, such as 10-30 bp, such as 20 bp.

[0111] In some embodiments, the oligonucleotide sequence capable of capturing mRNA comprises a sequence capable of hybridizing to the polyA tail of mRNA. In certain embodiments, the oligonucleotide sequence capable of capturing mRNA comprises a polyT oligonucleotide sequence. In certain embodiments, the polyT oligonucleotide sequence comprises at least 10 (e.g., at least 20) deoxythymidine residues.

[0112] In some embodiments, the capture sequence has a length of more than 1 bp, hi some embodiments, the capture sequence is between 1 and 100 bp in length, such as between 10 and 50 bp, such as between 10 and 30 bp.

[0113] Detection Method In a sixth aspect, the present invention provides a method for detecting spatial information of a nucleic acid in a sample, comprising the steps of: (1) providing a nucleic acid array according to the third aspect or obtaining a nucleic acid array by the method according to the first aspect; The nucleic acid array comprises multiple types of carrier sequences attached to a surface of a solid support (e.g., a chip), each type of carrier sequence occupies a different location in the array, and each type of carrier sequence comprises multiple copies of the carrier sequence; each copy of the carrier sequence comprises a hybridized first nucleic acid molecule and a second nucleic acid molecule, wherein the first nucleic acid molecule and the second nucleic acid molecule are not ligated to each other; a first nucleic acid molecule comprising a complement of a positioning sequence corresponding to the position of the carrier sequence of the type in the array; the second nucleic acid molecule comprises a capture sequence capable of capturing a nucleic acid in the sample; (2) contacting the nucleic acid array with the test sample under conditions that allow for annealing such that the nucleic acid in the test sample anneals to the capture sequence of the second nucleic acid molecule and the position of the nucleic acid can be correlated with the position of the carrier sequence on the nucleic acid array; (3)(i) ligating (e.g., using a ligase) the hybridized first and second nucleic acid molecules to each copy of the carrier sequence; performing a primer extension reaction using the ligated first and second nucleic acid molecules as primers and the captured nucleic acid molecule as a template under conditions allowing primer extension to produce an extension product, the strand that hybridizes to the captured nucleic acid molecule having the complement of the positioning sequence contained in the first nucleic acid molecule as a spatial information tag; and / or performing a primer extension reaction by using the captured nucleic acid molecule as a primer and using the ligated first and second nucleic acid molecules as templates under conditions allowing primer extension to result in a captured and extended nucleic acid molecule, the captured and extended nucleic acid molecule having a positioning sequence as a spatial information tag; Alternatively, (ii) performing a primer extension reaction by using the second nucleic acid molecule as a primer and the captured nucleic acid molecule as a template under conditions allowing primer extension to result in an extended second nucleic acid molecule, the extended second nucleic acid molecule comprising a complementary sequence of the captured nucleic acid; ligating (e.g., using a ligase) the extended second nucleic acid molecule to the first nucleic acid molecule, the extended second nucleic acid molecule being hybridized to each copy of the carrier sequence such that the extended second nucleic acid molecule has, as a spatial information tag, the complement of the positioning sequence contained in the first nucleic acid molecule; (4) releasing at least a portion of the nucleic acid molecules with spatial information tags from the surface of the array, the portion including the positioning sequence or its complementary strand and the captured nucleic acid molecule or its complementary strand; and (5) directly or indirectly analyzing the sequence information of the nucleic acid molecules released in step (4). The present invention provides a method comprising:

[0114] In such embodiments, in step (2), the first nucleic acid molecule is not ligated to a second nucleic acid molecule in the nucleic acid array before the target nucleic acid is captured.

[0115] In a seventh aspect, the present invention provides a method for detecting spatial information of a nucleic acid in a sample, comprising the steps of: (1) providing a nucleic acid array according to the first aspect or obtaining a nucleic acid array by the method according to the third aspect; The nucleic acid array comprises multiple types of carrier sequences attached to a surface of a solid support (e.g., a chip), each type of carrier sequence occupies a different location in the array, and each type of carrier sequence comprises multiple copies of the carrier sequence; each copy of the carrier sequence comprises a first nucleic acid molecule hybridized thereto, the first nucleic acid molecule being ligated to a second nucleic acid molecule; a first nucleic acid molecule comprising a complement of a positioning sequence corresponding to the position of the carrier sequence of the type in the array; the second nucleic acid molecule comprises a capture sequence capable of capturing a nucleic acid in the sample; (2) contacting the nucleic acid array with the test sample under conditions that allow for annealing such that the nucleic acid in the test sample anneals to the capture sequence of the second nucleic acid molecule and the position of the nucleic acid can be correlated with the position of the carrier sequence on the nucleic acid array; (3)(iii) performing a primer extension reaction by using the ligated first and second nucleic acid molecules as primers and the captured nucleic acid molecule as a template under conditions allowing primer extension to produce an extension product, the strand hybridized to the captured nucleic acid molecule having as a spatial information tag the complement of the positioning sequence contained in the first nucleic acid molecule; and / or performing a primer extension reaction by using the captured nucleic acid molecule as a primer and the ligated first and second nucleic acid molecules as templates under conditions that allow primer extension to yield a captured and extended nucleic acid molecule, wherein the captured and extended nucleic acid sequence has a positioning sequence as a spatial information tag; (4) releasing at least a portion of the nucleic acid molecules with spatial information tags from the surface of the array, the portion including the positioning sequence or its complementary strand and the captured nucleic acid molecule or its complementary strand; and (5) directly or indirectly analyzing the sequence information of the nucleic acid molecules released in step (4). The present invention provides a method comprising:

[0116] In such embodiments, in step (2), a first nucleic acid molecule is ligated to a second nucleic acid molecule in the nucleic acid array before the target nucleic acid is captured.

[0117] In certain embodiments of the method of the sixth or seventh aspect, the multiple copies of the carrier sequence are DNBs formed by concatemers of the carrier sequence, or the multiple copies of the carrier sequence are DNA clusters formed by a clonal population of the carrier sequence.

[0118] In certain embodiments of the method of the sixth or seventh aspect, the carrier sequence and the first nucleic acid molecule are single-stranded DNA. In certain embodiments, the second nucleic acid molecule is single-stranded DNA or single-stranded RNA.

[0119] In an eighth aspect, the present invention provides a method for detecting spatial information of a nucleic acid in a sample, comprising the steps of: (1) providing a nucleic acid array according to the fifth aspect or obtaining a nucleic acid array by a method according to the second aspect, the nucleic acid array comprising a plurality of types of carrier sequences attached to a surface of a solid support (e.g. a chip), each type of carrier sequence occupying a different position in the array, and each type of carrier sequence comprising a plurality of copies of the carrier sequence; each copy of the carrier sequence having hybridized thereto a first nucleic acid molecule, the first nucleic acid molecule comprising a complement of a positioning sequence corresponding to the position of that type of carrier sequence in the array, and a capture sequence capable of capturing a nucleic acid in the sample; (2) contacting the nucleic acid array with the test sample under conditions that allow for annealing such that a nucleic acid in the test sample anneals to the capture sequence of the first nucleic acid molecule and the position of the nucleic acid can be correlated with the position of the first nucleic acid molecule on the nucleic acid array; (3) performing a primer extension reaction by using the first nucleic acid molecule as a primer and the captured nucleic acid molecule as a template under conditions allowing primer extension to result in an extension product, the strand hybridized with the captured nucleic acid molecule having as a spatial information tag the complement of the positioning sequence contained in the first nucleic acid molecule; (4) releasing at least a portion of the nucleic acid molecules with spatial information tags from the surface of the array, the portion including the positioning sequence or its complementary strand and the captured nucleic acid molecule or its complementary strand; and (5) directly or indirectly analyzing the sequence information of the nucleic acid molecules released in step (4). The present invention provides a method comprising:

[0120] In some embodiments, prior to step (2), the method further comprises performing cleavage at a cleavage site contained in the first immobilized sequence of the carrier sequence to digest the carrier sequence and simultaneously ligating the first nucleic acid molecule (capture probe) to the surface of a solid support (e.g., a chip). In such embodiments, the nucleic acid array comprises multiple types of capture probes attached to the surface of the solid support (e.g., a chip), each type of capture probe occupies a different position in the array, and the capture probe comprises a complement of a positioning sequence corresponding to the position of the type of capture probe in the array, and a capture sequence capable of capturing a nucleic acid in a sample.

[0121] In some embodiments, the method comprises: (2) contacting the nucleic acid array with the test sample under conditions that allow for annealing such that nucleic acids in the test sample anneal to the capture sequences of the capture probes and the positions of the nucleic acids can be correlated with the positions of the capture probes on the array; (3) performing a primer extension reaction by using the capture probe as a primer and the captured nucleic acid molecule as a template under conditions allowing primer extension, the resulting extension product comprising the complement of the positioning sequence as the spatial information tag and the complementary sequence of the captured nucleic acid molecule, thereby generating a DNA molecule with a spatial information tag; optionally generating a complementary strand of the DNA molecule with the spatial information tag, and / or optionally amplifying the DNA molecule with the spatial information tag; (4) releasing at least a portion of the DNA molecules with spatial information tags and / or their complements or amplicons from the surface of the array, a portion of which contains the spatial information tag or its complement; and (5) directly or indirectly analyzing the sequence information of the nucleic acid molecules released in step (4). Further includes:

[0122] In some embodiments of the method of the eighth aspect, the first nucleic acid molecule and the capture probe are DNA molecules, such as single-stranded DNA.

[0123] In certain embodiments of the method of any one of the sixth to eighth aspects, the spatial information of the nucleic acid comprises the location, distribution, and / or expression of the nucleic acid.

[0124] In certain embodiments of the method of any one of the sixth to eighth aspects, the sample is a tissue sample, such as a tissue section. In certain embodiments, the tissue section is prepared from fixed tissue, such as formalin-fixed paraffin-embedded (FFPE) tissue, or flash-frozen tissue.

[0125] In certain embodiments of the method of any one of the sixth through eighth aspects, the method is used for non-diagnostic purposes.

[0126] In some embodiments of the method described in any one of the sixth to eighth aspects, any nucleic acid analysis method may be used in step (5). In certain embodiments, this step may include sequencing. In some embodiments, a sequence-specific analysis method may be used. For example, a sequence-specific amplification reaction may be performed, for example, using primers specific for the positioning domain and / or the specific target sequence (e.g., the specific target DNA to be detected). An exemplary analysis method is a sequence-specific PCR reaction. Thus, in certain embodiments, this step may include a sequence-specific PCR reaction.

[0127] In some embodiments of the method described in any one of the sixth to eighth aspects, the sequence analysis information obtained in step (5) may be used to obtain spatial information (i.e., location information) of the nucleic acid in the sample. In some embodiments, this spatial information may derive from the nature of the sequence analysis information determined, for example, this spatial information may itself provide spatial information in the context of the tissue sample used, may reveal the presence of a particular nucleic acid, and / or the spatial information (e.g., spatial localization) may derive from the location of the tissue sample in the array coupled with the sequencing information. Thus, the method may simply involve correlating the sequence analysis information with the location in the tissue sample, for example, by correlation of the positioning tag and the positioning tag with the location in the tissue sample. In some embodiments, the spatial information may be conveniently obtained by correlating the sequence analysis data with an image of the tissue sample. Thus, in such embodiments, the method of any one of the sixth to eighth aspects further comprises a step (6): correlating the sequence analysis information obtained in step (5) with an image for the sample, wherein the sample is imaged before or after step (3). In some embodiments, imaging the sample uses optical microscopy, bright field microscopy, dark field microscopy, phase contrast microscopy, fluorescence microscopy, reflected light microscopy, interference microscopy, confocal microscopy, or a combination thereof.

[0128] In certain embodiments of the method of the sixth aspect, the method is used to detect a transcriptome in a sample. In such embodiments, in step (3)(i), a cDNA molecule is generated from the captured RNA molecule by using the ligated first and second nucleic acid molecules as a reverse transcription primer, the cDNA molecule having a complement of the positioning sequence contained in the first nucleic acid molecule as a spatial information tag, and optionally the cDNA molecule is amplified; or in step (3)(ii), a cDNA molecule is generated from the captured RNA molecule by using the second nucleic acid molecule as a reverse transcription primer, the cDNA molecule having a complement of the positioning sequence contained in the first nucleic acid molecule as a spatial information tag, and optionally the cDNA molecule is amplified. The first nucleic acid molecule and the cDNA molecules hybridized with each carrier sequence are ligated (e.g., using a ligase) to generate cDNA molecules having the complement of the positioning sequence contained in the first nucleic acid molecule, and optionally the cDNA molecules are amplified; in step (4), at least a portion of the cDNA molecules and / or their amplicons are released from the surface of the array, and the released nucleic acid molecules can be the first and / or second strands of the cDNA molecules or their amplicons, some of which contain the spatial information sequence or its complementary strand. In some embodiments, in step (1), the capture sequence comprises an oligonucleotide sequence capable of capturing mRNA.

[0129] In certain embodiments of the method of the seventh aspect, the method is used to detect transcriptome in a sample. In such an embodiment, in step (3)(iii), a cDNA molecule is generated from the captured RNA molecule by using the ligated first and second nucleic acid molecules as reverse transcription primers, the cDNA molecule has the complement of the positioning sequence contained in the first nucleic acid molecule as a spatial information tag, and optionally the cDNA molecule is amplified; in step (4), at least a part of the cDNA molecule and / or their amplicons is released from the surface of the array, and the released nucleic acid molecule can be the first strand and / or the second strand of the cDNA molecule or its amplicons, and some of them contain spatial information sequence or its complement. In some embodiments, in step (1), the capture sequence comprises an oligonucleotide sequence capable of capturing mRNA.

[0130] In certain embodiments of the method of the eighth aspect, the method is used to detect transcriptome in a sample.In such embodiments, in step (3), the capture probe is used as an RT primer to generate cDNA molecules from the captured RNA molecules, the cDNA molecules have spatial information tags, and the cDNA molecules are optionally amplified; in step (4), at least some of the cDNA molecules and / or their amplicons are released from the surface of the array, and the released nucleic acid molecules can be the first and / or second strands of the cDNA molecules or their amplicons, some of which include spatial information tag sequences or their complementary strands.In some embodiments, in step (1), the capture sequence comprises an oligonucleotide sequence capable of capturing mRNA.

[0131] In some embodiments of the method of any one of the sixth to eighth aspects, a complementary or second strand of the cDNA is generated before or after the nucleic acid molecule (e.g., DNA molecule) with the spatial information tag or the cDNA molecule with the spatial information tag is released from the surface of the array.

[0132] The step to generate second strand DNA (e.g., cDNA) may be performed in situ on the array, either as a separate step of second strand synthesis or in the first step of an amplification reaction. Alternatively, the first strand DNA, e.g., cDNA (i.e., the strand generated by using the captured nucleic acid molecule as a template), may be released from the array and then second strand synthesis may be performed in a reaction carried out in solution, for example, whether as a separate step or in an amplification reaction.

[0133] When second strand synthesis is performed on the array (i.e., in situ), the method may include an optional step of removing the captured nucleic acid molecule (e.g., RNA) before second strand synthesis, for example, by using an RNA digesting enzyme (RNase), e.g., RNase H. Procedures for removing captured nucleic acid molecules are well known and described in the art. However, the removal step is generally unnecessary, and in most cases, RNA is naturally degraded. The step of removing the sample from the array generally also removes RNA from the array.

[0134] In some embodiments, the second strand of DNA (e.g., cDNA) is produced in a single reaction, and the synthesis of the second strand can be carried out by any suitable method known in the art.For example, the first strand of cDNA released from the array substrate can be incubated with random primers, e.g., hexamer primers, and DNA polymerase, e.g., strand-displacing polymerase, to carry out a DNA synthesis reaction using the first strand as a template.Thus, in certain embodiments, the synthesis of the complementary strand or second strand uses random primers and strand-displacing polymerase.

[0135] In some embodiments of the method according to any one of the sixth to eighth aspects, the method further comprises amplifying the nucleic acid molecule (e.g., DNA molecule) or the cDNA molecule with the spatial information tag before sequence analysis. In some embodiments, the amplification step is performed after the nucleic acid molecule (e.g., DNA molecule) or the cDNA molecule with the spatial information tag is released from the array, or the amplification step is performed in situ in the array (i.e., while the first nucleic acid molecule and / or the carrier sequence and / or the capture probe are still ligated to the surface of the solid support). In certain embodiments, the amplification step comprises PCR.

[0136] In some embodiments of the method described in any one of the sixth to eighth aspects, in step (4), the molecules are released from the surface of the array by the following methods: (i) a nucleic acid cleavage method; (ii) a nucleic acid denaturation method; and / or (iii) a physical method. In certain embodiments, the molecules are released by applying hot water or a buffer to the solid support.

[0137] In some embodiments, the further step includes purifying the released molecules prior to sequencing.

[0138] In some embodiments, the method further comprises the step of replenishing the sample with water after the sample has been contacted with the array and prior to step (3).

[0139] In some embodiments, prior to step (4), the method further comprises washing the array to remove any remaining sample (e.g., tissue).

[0140] In certain embodiments, the array includes at least one orientation marker that orients the samples in the array.

[0141] In some embodiments, in step (5), the sequence analysis step comprises a sequencing step. In some embodiments, the sequencing step comprises a reversible dye terminator-based sequencing reaction.

[0142] According to any one of the sixth to eighth aspects of the present invention, the method for detecting spatial information of nucleic acids can be used for RNA detection, transcriptome analysis, DNA detection, genome analysis, etc. The spatial information is of great importance for research studies related to transcriptomics and genomics, and is particularly useful in studying transcriptome or genome variations in different cell or tissue regions, such as comparative studies of normal cells or tissues and diseased cells or tissues, or studies of transcriptome or genome changes during disease processes.

[0143] For example, pathophysiological analysis of Alzheimer's disease shows that the pathological process of Alzheimer's disease involves interactions between neurons and glial cells, and related transcriptomic and epigenomic studies have also found that the brains of patients with Alzheimer's disease have severe impairment of neuronal function and abnormalities in innate immune response. However, population-level research studies cannot reveal the complexity of changes between cells and within cell populations, especially for rare cell types. Regular research studies at the single-cell level cannot distinguish the characteristics of specific cell types in different tissue regions during the same period and the changes in cell composition during neurodegeneration. Therefore, there is an urgent need to obtain single-cell transcriptomic information with spatial dimensions to further clarify the pathogenesis and development of the disease.

[0144] According to any one of the sixth to eighth aspects of the present invention, the method for detecting spatial information of nucleic acid can immobilize nucleic acid molecules in different regions of brain tissue samples to a chip via capture sequences with position tags ligated to the chip, and perform sequencing, so as to obtain transcriptome results with accurate position information, so as to realize the detection of changes in specific cell types in different regions during the progression of Alzheimer's disease.In particular, since the active region of DNB or DNA cluster in the chip of the present invention is at a fine grade of nanometers, while the diameter of a cell is about 12um, the chip of the present invention can obtain spatial positioning information with intracellular resolution.

[0145] The present invention also includes the following exemplary embodiments: Item 1. A method for producing a nucleic acid array used to detect spatial information of biomolecules (e.g., nucleic acids) in a sample, comprising the steps of: (1) providing a circular nucleic acid template, the circular nucleic acid template comprising a template sequence of one type of capture probe, the template sequence comprising, in a 5' to 3' direction, a linker region, a spatial tag region, and a capture region; The linker region may comprise a cleavage site, and cleavage may be selected from enzymatic cleavage by a nicking enzyme, enzymatic cleavage by a USER enzyme, photocleavage, chemical cleavage, or CRISPR-based cleavage; the spatial tag region comprises a spatial tag sequence, the spatial tag sequence corresponding to the position of the capture probe type in the array; The capture region comprises a capture sequence capable of capturing a biomolecule (e.g., a nucleic acid) in a sample; the capture sequence comprises (1a) an oligonucleotide sequence capable of capturing mRNA; and / or (1b) a random or degenerate oligonucleotide sequence; or (c) a sequence specific for a particular target molecule (e.g., a target nucleic acid). Steps; (2) performing rolling circle amplification (RCA) by using the circular nucleic acid template as a template to obtain DNBs (DNA nanoballs) formed by concatemers of complementary sequences of the template sequence (i.e., sequences complementary to the template); (3) ligating the DNB to the surface of a solid support (e.g., a chip); (4) providing a probe primer and performing a primer extension reaction using the template-complementary sequence contained in the DNB as a template to produce an extension product, the strand hybridized to the template-complementary sequence being the capture probe; optionally amplifying the extension product; the probe primer comprising, in the 5' to 3' direction, a binding region, a cleavage region, and a primer linker region; the binding region comprises a linker capable of ligating to a surface of a solid support; the cleavage region comprises a cleavage site; The primer linker region is complementary to all or a part of the sequence of the linker region of the template-complementary sequence (i.e., the complementary sequence of the linker region of the template sequence) contained in the DNB, and has a free 3' end so that the probe primer can function as a primer and trigger an extension reaction; preferably, the primer linker region includes the sequence of the linker region of the template sequence or a fragment thereof. Steps; (5) ligating the probe primer to the surface of the solid support, wherein steps (4) and (5) are performed in any order; (6) The extension product in step (4) is separated from the template DNB, thereby forming an extension product, thereby ligating the capture probe to the surface of a solid support (e.g., a chip); Preferably, the circular nucleic acid template, the DNB, and the capture probe are DNA; Preferably, multiple types of circular nucleic acid templates are provided in step (1), each type of circular nucleic acid template containing a different template sequence of the capture probe, to obtain a solid support (e.g., a chip) having multiple types of capture probes attached to its surface. Steps The method includes:

[0146] Item 2. The cleavage site contained in the linker region is a cleavage site for a nicking enzyme; Preferably, the nicking enzyme is selected from USER, BamHI, and BmtI. The method according to item 1.

[0147] Item 3. The linker region further comprises a hybridization region for a sequencing primer and / or a hybridization region for an amplification primer; the hybridization region for the sequencing primer allows annealing to the sequencing primer and triggering a sequencing reaction, and the hybridization region for the amplification primer allows annealing to the amplification primer and triggering an extension reaction and an amplification reaction; 3. The method according to item 1 or 2.

[0148] Item 4. The oligonucleotide sequence capable of capturing mRNA comprises a sequence capable of hybridizing with the polyA tail of mRNA; Preferably, the oligonucleotide sequence capable of capturing mRNA comprises a poly-T oligonucleotide sequence; Preferably, the poly-T oligonucleotide sequence contains at least 10 (e.g., at least 20) deoxythymidine residues. The method according to any one of items 1 to 3.

[0149] Item 5. The template sequence further comprises a probe tag region disposed upstream of the capture region and downstream of the linker region, the probe tag region comprising a sequence complementary to the probe tag, the sequence being composed of modified bases, the modified bases being capable of complementary pairing with multiple types of primary bases (e.g., C, G, A, T, U) through hydrogen bonding; Preferably, the probe tag region is located between the spatial tag region and the capture region, or between the linker region and the spatial tag region; Preferably, the sequence complementary to the probe tag contains multiple (e.g., at least 10) inosines. The method according to any one of items 1 to 4.

[0150] Item 6. Features as follows: (i) the linker region has a length of more than 1 bp, for example, more than 10 bp or more than 20 bp; preferably, the linker region has a length of 20 to 100 bp; (ii) the spatial tag region has a length of more than 1 bp, e.g., more than 10 bp; preferably, the spatial tag region has a length of 10 to 100 bp; (iii) the capture region has a length of greater than 1 bp; preferably, the capture region has a length of 1-100 bp; (iv) the probe tag region has a length of more than 1 bp, for example, more than 5 bp; preferably, the probe tag region has a length of 5 to 100 bp. The method according to any one of items 1 to 5, comprising one or more of the following steps:

[0151] Item 7. The solid support is a chip; Preferably, the solid support can be used as a sequencing platform, such as a sequencing chip. The method according to any one of items 1 to 6.

[0152] Item 8. The method according to any one of items 1 to 7, wherein in step (4), the complementary sequence of the spatial tag sequence is sequenced during the primer extension reaction to obtain sequence information of the spatial tag sequence contained in the corresponding capture probe.

[0153] Item 9. Before step (4), the method further includes sequencing a complementary sequence of the spatial tag sequence contained in the DNB; Preferably, after sequencing is completed, washing removes the dNTPs added to the synthetic strand for sequencing. The method according to any one of items 1 to 7.

[0154] Item 10. The linker is a linking group capable of coupling with an activating group (e.g., NH2), and the solid support is modified on the surface with an activating group (e.g., NH2); Preferably, the linker comprises -SH, -DBCO, or -NHS; Preferably, the linker is [ka] and [ka] is attached to the surface of a solid support; The method according to any one of items 1 to 9.

[0155] Item 11. The cleavage site contained in the cleavage region is a site at which controlled cleavage can be performed by chemical, enzymatic, or photochemical methods; Preferably, the cleavage site is an enzymatic cleavage site; Preferably, the cleavage site contained in the cleavage region is different from the linker region. The method according to any one of items 1 to 10.

[0156] Item 12. The method of any one of items 1 to 11, wherein the amplification comprises PCR.

[0157] Item 13. A nucleic acid array prepared by the method according to any one of items 1 to 12.

[0158] Item 14. A nucleic acid array for detecting spatial information of biomolecules (e.g., nucleic acids) in a sample, comprising a solid support (e.g., a chip) having a plurality of types of capture probes attached to its surface, each type of capture probe occupying a different position in the array and oriented to have a free 3' end to enable the capture probe to function as an extension primer, each type of capture probe comprising, in the 5' to 3' direction, a binding region, a cleavage region, a spatial tag sequence, and a capture sequence; the binding region comprises a linker capable of ligating to a surface of a solid support; the cleavage region comprises a cleavage site; the spatial tag sequence corresponds to the location of that type of capture probe in the array; The capture sequence is capable of hybridizing to all or a portion of a biomolecule (e.g., a nucleic acid) to be captured and includes (1a) an oligonucleotide sequence capable of capturing mRNA; and / or (1b) a random or degenerate oligonucleotide sequence; or (c) a sequence specific to a particular target molecule (e.g., a target nucleic acid). Nucleic acid arrays.

[0159] Item 15. Each capture probe of each type (i.e., capture probes containing the same spatial tag sequence) has a different probe tag sequence, and the probe tag sequence is located upstream of the capture sequence and downstream of the cleavage region; Preferably, the probe tag sequence is located between the capture sequence and the spatial tag sequence, or between the cleavage region and the spatial tag sequence. 15. The nucleic acid array of item 14.

[0160] Item 16. Each type of capture probe (i.e., capture probes containing the same spatial tag sequence) occupies an area on the surface of the solid support that is less than 1 micron in diameter (i.e., active area); Preferably, each type of capture probe occupies an active area having a diameter of about 500 nanometers. 16. The nucleic acid array according to item 14 or 15.

[0161] Item 17. The solid support is a chip; Preferably, the solid support can be used as a sequencing platform, such as a sequencing chip. 17. The nucleic acid array according to any one of items 14 to 16.

[0162] Item 18. The nucleic acid array according to any one of Items 14 to 17, prepared by the method according to any one of Items 1 to 12.

[0163] Item 19. A method for detecting spatial information of biomolecules in a sample, comprising the steps of: (1) preparing a nucleic acid array according to any one of items 13 to 18, or obtaining a nucleic acid array by the method according to any one of items 1 to 12; the nucleic acid array comprises a plurality of types of capture probes attached to a surface of a solid support (e.g., a chip), each type of capture probe occupies a different position in the array, and the capture probe comprises a spatial tag sequence corresponding to the position of the type of capture probe in the array, and a capture sequence capable of capturing a biomolecule in a sample; (2) contacting the nucleic acid array with the test sample such that the capture sequence of the capture probe binds to a biomolecule in the test sample, thereby providing a biomolecule labeled with a spatial tag such that the position of the biomolecule can be correlated with the position of the capture probe on the nucleic acid array; (3) releasing the spatially tagged biomolecules from the surface of the array; and (4) directly or indirectly analyzing the sequences of the biomolecules released in step (3). The method includes:

[0164] Item 20. A method for detecting spatial information of a nucleic acid in a sample, comprising the steps of: (1) preparing a nucleic acid array according to any one of items 13 to 18 or obtaining a nucleic acid array by the method according to any one of items 1 to 12, wherein the nucleic acid array comprises a plurality of types of capture probes attached to a surface of a solid support (e.g., a chip), each type of capture probe occupies a different position in the array, and the capture probe comprises a spatial tag sequence corresponding to the position of the type of capture probe in the array and a capture sequence capable of capturing a nucleic acid in a sample; (2) contacting the nucleic acid array with the test sample under conditions that allow for annealing such that nucleic acids in the test sample anneal to the capture sequences of the capture probes, such that the positions of the nucleic acids can be correlated with the positions of the capture probes on the array; (3) performing a primer extension reaction using the capture probe as a primer and the captured nucleic acid molecule as a template under conditions that allow primer extension, where the resulting extension product comprises the spatial tag sequence and a complementary sequence of the captured nucleic acid molecule, thereby resulting in a DNA molecule labeled with a spatial tag; optionally providing a complementary strand of the DNA molecule labeled with the spatial tag, and / or optionally amplifying the DNA molecule labeled with the spatial tag; (4) releasing at least a portion of the DNA molecules labeled with spatial tags, and / or their complements or amplicons, from the surface of the array, a portion of which includes the spatial tag sequence or its complement; and (5) directly or indirectly analyzing the sequences of the nucleic acid molecules released in step (4); Preferably, the spatial information of the nucleic acid comprises the location, distribution, and / or expression of the nucleic acid; Preferably, the capture probe is a DNA molecule; Preferably, the sample is a tissue sample, such as a tissue section; Preferably, the tissue sections are prepared from fixed tissue, e.g., formalin-fixed paraffin-embedded (FFPE) tissue, or flash-frozen tissue. Steps The method includes:

[0165] Item 21. The method according to Item 20, wherein in step (5), the sequence analysis comprises sequencing or a sequence-specific PCR reaction.

[0166] Item 22. Step (6): The method according to Item 20 or 21, further comprising a step of correlating the sequence analysis information obtained in step (5) with an image of the sample, wherein the sample is imaged before or after step (3).

[0167] Item 23. Used to detect the transcriptome in a sample, In step (3), the capture probe is used as an RT primer to synthesize cDNA molecules from the captured RNA molecules, the cDNA molecules are labeled with spatial tags, and optionally the cDNA molecules are amplified; In step (4), at least a portion of the cDNA molecules and / or their amplicons are released from the surface of the array, the released nucleic acid molecules can be first and / or second strands of the cDNA molecules or their amplicons, some of which include spatial tag sequences or their complementary strands; Preferably, in step (1), the capture sequence comprises an oligonucleotide sequence capable of capturing mRNA; The method according to any one of Items 20 to 22.

[0168] Item 24. The complementary strand or second strand of cDNA is provided before or after the spatially tagged DNA molecule or the spatially tagged cDNA molecule is released from the surface of the array; Preferably, the synthesis of the complementary or second strand uses random primers and a strand-displacing polymerase. The method according to any one of Items 20 to 23.

[0169] Item 25. The method further comprises amplifying the DNA or cDNA molecules labeled with spatial tags prior to sequence analysis; Preferably, the amplification step is performed after the DNA or cDNA molecules labeled with spatial tags are released from the array, or the amplification step is performed in situ on the array; Preferably, the amplification step comprises PCR. The method according to any one of Items 20 to 24.

[0170] Item 26. The method of any one of Items 20 to 25, wherein the sequence analysis further comprises a step of purifying the released molecules.

[0171] Item 27. The method of any one of Items 20 to 26, further comprising washing the array to remove any remaining sample (e.g., tissue) prior to step (4).

[0172] Item 28. In step (4), the molecules are released from the surface of the array by the following methods: (i) a nucleic acid cleavage method; (ii) a nucleic acid denaturation method; and / or (iii) a physical method; Preferably, the molecule is released from the cleavage region of the capture probe by enzymatic cleavage. The method according to any one of Items 20 to 27.

[0173] Item 29. The method according to any one of Items 20 to 28, wherein in step (6), the sample is imaged using optical microscopy, bright-field microscopy, dark-field microscopy, phase contrast microscopy, fluorescence microscopy, reflected light microscopy, interference microscopy, confocal microscopy, or a combination thereof.

[0174] The invention will now be described with reference to the following examples, which are intended to illustrate the invention rather than limit it.

[0175] Unless otherwise specified, the experiments and methods described in the examples were essentially carried out according to conventional methods well known in the art and described in various references. In addition, for the experiments and methods without specific conditions in the examples, these experiments and methods were carried out according to conventional conditions or conditions recommended by the manufacturer. All reagents or measuring instruments used without manufacturer's instructions were commercially available conventional products. Those skilled in the art will be aware that the examples are described for illustrative purposes of the present invention and are not intended to limit the scope of protection claimed by the present invention. All publications and other references mentioned herein are incorporated by reference in their entirety. EXAMPLES

[0176] Example 1. Preparation of capture chip (1) 1. The following DNA library sequences were designed and synthesized: The synthesis of sequences was performed by Beijing Liuhe BGI.

[0177] 5'-phosphorylated-AAGTCGGAGGCCAAGCGGTCTTAGGAAGACAA (Linker A, SEQ ID NO: 1) NNNNNNNNNNNNNNNNNNNNNNNNNNN (complement of positioning sequence, where N represented any base such as C, G, A, or T) CTGATAAGGTCGCCA (complement of second immobilized sequence, SEQ ID NO: 2) CAACTCCTTGGCTCACAGAACGACATGGCTACGATCCGACTT (Linker B, SEQ ID NO: 3) -3', where Linker A contained a portion of the complement of the first immobilized sequence and a circularization site, and Linker B contained another portion of the complement of the first immobilized sequence, a cleavage site, and a circularization site.

[0178] 2. In situ library amplification Preparation of DNB (DNA nanoball): 40 ul of the following reaction system was prepared and added with 80 femtomoles of the above DNA library, where the DNB primer had the sequence GGCCTCCGACTTAAGTCGGATCGT (SEQ ID NO: 4) and was synthesized by Beijing Liuhe BGI. [Table 1]

[0179] The above reaction system was put into a PCR machine for reaction. The reaction conditions were as follows: 95°C for 3 minutes, 40°C for 3 minutes; after reaction, the reaction system was placed on ice, and 40ul of mixed enzyme I and 2ul of mixed enzyme II, which are required to prepare DNB in ​​DNBSEQ sequencing kit, were added, as well as 1ul of ATP (100mM mother solution, Thermo Fisher) and 0.1ul of T4 ligase (BGI). After thorough mixing, the above reaction system was transferred to a PCR machine at 30°C and reacted for 20 minutes to form DNB. The DNB was loaded into a BGISEQ500 sequencing chip according to the method described in the BGISEQ500 SE50 kit.

[0180] 3. Sequencing and deciphering of positioning sequence: According to the instruction manual of BGISEQ500 SE50 sequencing kit, decipher the positioning sequence and sequence the sequencing length as 25bp. The fq file formed by sequencing was saved for later use.

[0181] 4. Immobilized capture sequence: The following DNA sequence was synthesized by Beijing Liuhe BGI: 5'-phosphorylated-CTGATAAGGTCGCCA (complement of the second immobilized sequence, SEQ ID NO: 5) NNNNNNNNNN (UMI) TTTTTTTTTTTTTTTTTTTVN (capture sequence, SEQ ID NO: 6)-3' [wherein N represented any base (e.g., C, G, A, or T)]. The sequencing chip was removed from the sequencer, and the cleavage reagent from Hole 7 of the BGISEQ500 SE50 kit was pumped onto the chip (ensuring that the reagent covered the entire chip and no air bubbles were generated). The chip was placed at 60°C and the reaction was carried out for 10 minutes. After the reaction, an appropriate amount of 5x concentrated SSC (purchased from Shanghai Shenggong) was pumped into the sequencing chip to replace the existing reagent on the chip. The capture sequence was diluted to 1 uM with 5x SSC, and an appropriate amount of the diluted capture sequence was added to the chip so that the chip was filled with the capture sequence. The chip was left at room temperature for about 30 minutes to allow the capture sequence to completely hybridize with the DNB.

[0182] 5. Dividing the chip: The prepared chip was cut into several pieces, where the size of the pieces was adjusted according to the experimental needs, and the chip was immersed in 50 mM Tris buffer with pH 8.0 and stored at 4°C for later use.

[0183] Example 2. Capture of tissue mRNA and synthesis of cDNA 1. Frozen Tissue Sections. Mouse cerebellar tissue sections were prepared according to standard procedures for frozen sections.

[0184] 2. Capture of mRNA. According to the size of tissue section, the chip of suitable size prepared in Example 1 was taken out and left at room temperature. After the liquid in the chip was evaporated, the tissue section was attached to the capture chip by the temperature difference between the tissue section and the chip in the tissue chopper. The attached tissue section was left at room temperature, and 5 times concentrated SSC reaction solution was added to the chip (and completely covered the area where the tissue was attached), and the reaction was carried out at 30°C for 30 minutes to completely hybridize the mRNA in the tissue with the capture area in the chip.

[0185] 3. cDNA synthesis. The chip was washed twice at room temperature using 5x SSC, and the following 200ul of reverse transcriptase reaction system was prepared. The reaction solution was added to the chip to completely cover the chip, and the reaction was carried out at 42°C for 90-180 minutes. cDNA synthesis was carried out using polyT as a primer for mRNA, and the 3' end of the mRNA had a TSO tag (AAGTCGGAGGCCAAGCGGTC / rG / / rG / / iXNA_G / ) (SEQ ID NO: 7) for the synthesis of a cDNA complementary strand. A structural schematic diagram of the above process is shown in Figure 1. [Table 2]

[0186] 4. Ligation of spatial positioning region to capture region. After cDNA synthesis, the chip was washed twice with 5x SSC. 1ml of the following reaction was prepared and the appropriate volume of reaction was pumped into the chip to ensure that the chip was filled with the following ligation reaction solution and ligate the nicks shown in Figure 1. The reaction was carried out at room temperature for 30 minutes. After the reaction, the chip was washed three times with 5x SSC at 55°C for 5 minutes each time. [Table 3]

[0187] 5. Release of cDNA. After the first strand of cDNA was synthesized in the chip, an appropriate amount of formamide solution was added to the chip and reacted at 55°C for 10 minutes to release the cDNA from the chip. The released molecule had the structure shown in Figure 2. The reaction solution released from the chip was collected, and the cDNA strand was purified using 2x concentration XP magnetic beads, and finally, the product was collected using 45ul of TE buffer (Thermo Fisher). The single-stranded cDNA was quantitatively detected using Qubit ssDNA detection kit.

[0188] 6. Amplification of cDNA. Prepare 100 ul of the following reaction: [Table 4]

[0189] The above reaction system was put into a PCR machine with the following reaction program: 95°C for 3 minutes, 11 cycles (98°C for 20 seconds, 58°C for 20 seconds, 72°C for 3 minutes), 72°C for 5 minutes, and 4°C for infinite time. After the reaction was completed, it was purified and collected using XP beads. The concentration of dsDNA was quantified using Qubit kit, and the distribution of cDNA fragments was detected using 2100. The detection result of 2100 case was shown in Figure 3. The length of cDNA was normal.

[0190] Example 3. Construction and sequencing of cDNA libraries 1. Tn5 interruption. According to the concentration of cDNA, 20ng of cDNA was added with 0.5uM Tn5 enzyme and corresponding buffer (the coating method for Tn5 enzyme was performed according to stLFR library construction kit) and mixed well to form 20ul reaction system. The reaction was carried out at 55℃ for 10 minutes, and 5ul of 0.1% SDS was added and mixed well for 5 minutes at room temperature to finish the Tn5 interruption step.

[0191] 2. PCR Amplification. Prepare 100 ul of the following reactions: [Table 5]

[0192] After mixing, the reaction was placed in a PCR machine with the following program: 95°C for 3 min, 11 cycles (98°C for 20 sec, 58°C for 20 sec, 72°C for 3 min), 72°C for 5 min, and 4°C for infinity. After the reaction was completed, it was purified and collected using XP beads. The dsDNA concentration was quantified using Qubit kit.

[0193] 3. Sequencing. After the above interruption, 80 femtomoles of amplification product was taken to prepare DNB. 40 ul of the following reaction was prepared: [Table 6]

[0194] The above reaction system was placed in a PCR machine for reaction, and the reaction conditions were as follows: 95°C for 3 minutes, 40°C for 3 minutes. After the reaction was completed, the reaction system was placed on ice, and 40ul of mixed enzyme I and 2ul of mixed enzyme II, which are required for preparing DNB in ​​DNBSEQ sequencing kit, were added, as well as 1ul of ATP (100mM mother solution, Thermo Fisher), 0.1ul of T4 ligase (BGI). After thorough mixing, the above reaction system was transferred to a PCR machine at 30°C and reacted for 20 minutes to form DNB. Following the method described in the MGISEQ2000 PE50 kit, the DNBs were loaded onto the MGISEQ2000 sequencing chip and sequencing was performed according to the instructions associated with the PE50 sequencing model, where the sequencing of the first strand was divided into two steps, i.e., 25 bp was sequenced, then a dark reaction was performed for 15 cycles, then 10 bp of UMI sequence was sequenced, and for the second strand, 50 bp was sequenced.

[0195] 4. Data Analysis 1. The 25bp sequence of the first strand obtained by cDNA sequencing was matched with the fq of the positioning sequence in the capture chip (the sequencing result obtained in step 3 of Example 1) by alignment. The matching result is shown in Figure 4, where the bright area represents the area where the 25bp of cDNA sequencing is exactly matched with the capture chip, and this area represents the area for tissue capture in the capture chip. This result showed that the capture chip can accurately locate the tissue capture area using the spatial positioning area.

[0196] 2. The DNBs matched with the capture chip were further analyzed by cDNA sequencing, and alignment analysis was performed between the sequencing results (mRNA expression in reaction tissues) of the second strand of cDNA of these DNB reads and the mouse genome. For the DNBs aligned to the mouse genome, the information of mouse mRNA was aligned to the capture chip through the sequencing results of 25bp. As shown in Figure 5, the left side shows a complete overview of the mRNA expression in the analyzed tissue section, and the overview shows that this capture chip can analyze the difference in mRNA expression in tissues; the right side of Figure 5 shows the tissue expression level of randomly selected genes expressed in mouse cerebellum, which indicates that this chip can analyze the difference in expression of a certain gene in all tissues.

[0197] Example 4. Preparation of capture chip (2) 1. The following DNA library sequences were designed and synthesized: The synthesis of sequences was performed by Beijing Liuhe BGI.

[0198] 5'-phosphorylated-GAACGACATGGCTTTTTCCCGTAGCCATGTCGTTCTGCGCCTTCCCGATG (immobilized sequence 1, SEQ ID NO: 12) NNNNNNNNNNNNNNNNNNNNNN (positioning sequence template, N represented any base, e.g., C, G, A, or T) IIIIIIIIII (UMI template, I represented inosine) TTTTTTTTTTTTTTTTTTTTTT (capture sequence, SEQ ID NO: 13) CCTCAGC (cleavage site, SEQ ID NO: 14) CCTTGGCTCACA (immobilized sequence 2, SEQ ID NO: 15) [wherein immobilized sequence 1 comprised a partial sequence of the complement of the first immobilized sequence and a circularization site, and immobilized sequence 2 comprised a partial sequence of the complement of the first immobilized sequence and a circularization site].

[0199] 2. In situ library amplification Preparation of DNB (DNA nanoball): 40 ul of the following reaction system was prepared and added with 80 femtomoles of the DNA library mentioned above, where the DNB primer has the sequence GACATGGCTACGTGTGAGCCAAGG (SEQ ID NO: 16) and was synthesized by Beijing Liuhe BGI. [Table 7]

[0200] The above reaction system was put into a PCR machine for reaction, and the reaction conditions were as follows: 95°C for 3 minutes, 40°C for 3 minutes; after reaction, the reaction system was placed on ice, and 40ul of mixed enzyme I and 2ul of mixed enzyme II, as well as 1ul of ATP (100mM mother solution, Thermo Fisher), 0.1ul of T4 ligase (BGI), which are required for preparing DNB in ​​DNBSEQ sequencing kit, were added. After thorough mixing, the above reaction system was transferred to a PCR machine at 30°C and reacted for 20 minutes to form DNB. The DNB was loaded into a BGISEQ500 sequencing chip according to the method described in the BGISEQ500 SE50 kit.

[0201] 3. Decoding spatial information (1) Chip surface modification: The surface of the BGISEQ-500 platform chip described above was contacted with an Azido-dPEG® 8-NHS ester having the following structure: [ka]

[0202] Surface modification of the chip was carried out according to the following method: The concentration of NHS-PEG8-azide (564.58 g per mole) was 45 μM, and 100 ml was prepared by the following method: [Table 8]

[0203] It was stored at -20°C, avoiding repeated freezing and drying.

[0204] The DBCO primer had a concentration of 1 uM but was diluted in PBS.

[0205] (2) Primer-probe coupling: The following primer probe sequences were synthesized by Beijing Liuhe BGI.

[0206] DBCO (linking group)-UUU (USER cleavage site) TTTTTCCCGTAGCCATGTCGTTCTGCGCCTTCCCGATG (SEQ ID NO: 17, this sequence included the complement of the first immobilized sequence, the PCR amplification site sequence, and the middle sequence). 1 uM of the above primer probe was diluted with PBS, introduced into the azide-modified chip, and reacted at room temperature for 1 hour or overnight.

[0207] (3) Decoding of spatial information. According to the instructions of the BGISEQ500 SE50 sequencing kit, the sequence of spatial information was decoded and sequenced with a sequencing length of 30 bp (the first 20 bp was the spatial information sequence, and the last 10 bp was the probe tag sequence). The fq file formed by sequencing was saved for later use.

[0208] (4) Synthesis of the capture domain: A mixed solution of dTTP and Hifi polymerase was prepared, and the oligo dT sequence was extended using DNB as a template, a probe sequence containing the spatial positioning region as a primer, and dTTP as a substrate.

[0209] 4. Release of probes containing spatial information 1 uM Spatial_RNA_BbvCI primer (diluted with 5x SSC) was prepared, and the primer sequence CCTCAGCCAACTCCT (SEQ ID NO: 18) was synthesized by Beijing Liuhe BGI. Hybridization was performed at room temperature for 30 minutes. BbvCI excision system (1.5 ml): 15 ul RE + 150 ul 10x CS buffer + 1335 ul ddH2O was prepared, and after the spatial positioning region was decoded, it was introduced into the chip and the reaction was performed at 37°C for 1 hour or overnight. Washing was performed twice by adding WB2 from the sequencing kit (MGI), and then the reaction was performed using formamide at 55°C for 15 minutes, followed by washing twice with WB2. A schematic diagram of the obtained probe is shown in Figure 7, and the probe sequence was as follows: UUU (cleavage region) TTTTTCCCGTAGCCATGTCGTTCTGCGCCTTCCCGATG (complement of first immobilized sequence, SEQ ID NO: 19) NNNNNNNNNNNNNNNNNNN (complement of positioning sequence, which was the same as the positioning sequence template in the sequence of the DNA library in step 1) NNNNNNNNNN (UMI sequence, which was the complement of the random base sequence obtained from the UMI template used as the template in step 1) TTTTTTTTTTTTTTTTTTT (capture sequence, SEQ ID NO: 20)

[0210] 5. Tip splitting The prepared capture chip was cut into several pieces, the size of the pieces was adjusted according to the experimental needs, and the chip was immersed in 50 mM Tris buffer with pH 8.0 and stored at 4°C for later use.

[0211] Example 5. Capture of tissue mRNA and synthesis of cDNA 1. Frozen Tissue Sections. Mouse cerebellar tissue sections were prepared according to standard procedures for frozen sections.

[0212] 2. Capture of mRNA. According to the size of tissue section, the chip of appropriate size prepared in Example 4 was taken out and left at room temperature. After the liquid in the chip was evaporated, the tissue section was attached to the capture chip by the temperature difference between the tissue section and the chip in the tissue chopper. The attached tissue section was left at room temperature, and 5 times concentrated SSC reaction solution was added to the chip (and completely covered the area where the tissue was attached), and the reaction was carried out at 30°C for 30 minutes to completely hybridize the mRNA in the tissue with the capture area in the chip.

[0213] 3. cDNA synthesis. The chip was washed twice at room temperature using 5x SSC, and the following 200ul of reverse transcriptase reaction system was prepared. The reaction solution was added to the chip to completely cover the chip, and the reaction was carried out at 42°C for 90-180 minutes. The mRNA used polyT as a primer for cDNA synthesis, and the 3' end of the mRNA had a TSO tag (CGTAGCCATGTCGTTCTGCG / rG / / rG / / iXNA_G / ) (SEQ ID NO: 21) for the synthesis of the cDNA complementary strand. A structural schematic diagram of the above process is shown in FIG. 8. [Table 9]

[0214] 4. Release of cDNA. After the first strand of cDNA was synthesized on the chip, the USER enzyme reaction system was prepared and the reaction was carried out according to the instruction manual of the USER enzyme. The released molecule had the structure shown in Figure 9. The reaction solution released from the chip was collected, and the first strand of cDNA was purified using 2x concentration XP magnetic beads, and finally the product was collected using 45ul of TE buffer (Thermo fisher).

[0215] 5. Amplification of cDNA. Prepare 100 ul of the following reaction: [Table 10]

[0216] The above reaction system was transferred to a PCR machine and the following reaction program was set: 95°C for 3 minutes, 11 cycles (98°C for 20 seconds, 58°C for 20 seconds, 72°C for 3 minutes), 72°C for 5 minutes, and 4°C for infinite time. After the reaction was completed, it was purified and collected using XP beads. The concentration of dsDNA was quantified using Qubit kit, and the distribution of cDNA fragments was detected using 2100. The test result of 2100 case is shown in Figure 10, where the length of cDNA was normal.

[0217] Example 6. Construction and sequencing of cDNA libraries 1. Tn5 interruption. According to the concentration of cDNA, 20ng of cDNA was added with 0.5uM Tn5 enzyme and corresponding buffer (the coating method for Tn5 enzyme was performed according to stLFR library construction kit) and mixed thoroughly to form 20ul reaction system. The reaction was carried out at 55℃ for 10 minutes, and 5ul of 0.1% SDS was added and mixed at room temperature for 5 minutes to finish the Tn5 interruption step.

[0218] 2. PCR Amplification. Prepare 100 ul of the following reactions: [Table 11]

[0219] After mixing, the reaction was placed in a PCR machine with the following program: 95°C for 3 min, 11 cycles (98°C for 20 sec, 58°C for 20 sec, 72°C for 3 min), 72°C for 5 min, and 4°C for infinity. After the reaction was completed, it was purified and collected using XP beads. The dsDNA concentration was quantified using the Qubit kit.

[0220] 3. Sequencing. To prepare DNB, 80 femtomoles of the amplification product after the above interruption was taken. 40 ul of the following reaction system was prepared: [Table 12]

[0221] The above reaction system was put into a PCR machine for reaction, and the reaction conditions were as follows: 95°C for 3 minutes, 40°C for 3 minutes. After reaction, the reaction system was placed on ice, and 40ul of mixed enzyme I and 2ul of mixed enzyme II, which are required for preparing DNB in ​​DNBSEQ sequencing kit, were added, as well as 1ul of ATP (100mM mother solution, Thermo Fisher) and 0.1ul of T4 ligase (BGI). After thorough mixing, the above reaction system was transferred to a PCR machine at 30°C and reacted for 20 minutes to form DNB. Following the method described in the MGISEQ2000 PE50 kit, the DNBs were loaded onto the MGISEQ2000 sequencing chip, and sequencing was performed in customer sequencing mode according to the relevant instructions, with the first strand sequencing being divided into two steps, i.e., 20 bp was sequenced, then the 10 bp probe tag sequence was sequenced, and for the second strand, 50 bp was sequenced.

[0222] 4. Data Analysis 1. The 20bp sequence of the first strand obtained by cDNA sequencing was matched with the spatial information sequence fq in the chip (the sequencing result obtained in step 3 of Example 4) by alignment. The matching result is shown in Figure 11, where the bright area represents the area where the 20bp of cDNA sequencing is exactly matched with the capture chip, and this area represents the area for tissue capture in the capture chip. This result shows that the capture chip can use the spatial positioning area to accurately locate the tissue capture area.

[0223] 2. The DNBs matched with the capture chip were further analyzed by cDNA sequencing, and alignment analysis was performed between the sequencing results (mRNA expression in reaction tissues) of the second strand of cDNA of these DNB reads and the mouse genome. For the DNBs aligned to the mouse genome, the information of mouse mRNA was aligned to the capture chip through the sequencing results of 20bp. As shown in Figure 12, the left side shows the overall picture of mRNA expression in the analyzed tissue section, and the overall picture shows that this capture chip can analyze the difference in mRNA expression in tissue; the right side of Figure 12 shows the tissue expression level of randomly selected genes expressed in mouse cerebellum, which indicates that this chip can analyze the difference in expression of a certain gene in all tissues.

[0224] Although the specific embodiments of the present invention have been described in detail, those skilled in the art will understand that, according to all the teachings disclosed, various modifications and changes may be made to the details, and these modifications are within the scope of protection of the present invention. All of the present invention is provided by the appended claims and any equivalents thereof.

Claims

1. A nucleic acid array for detecting spatial information of nucleic acids in a sample, comprising a solid support (e.g., a chip) having multiple types of carrier sequences attached to a surface, each type of carrier sequence occupying a different position in the array, each type of carrier sequence comprising multiple copies of the carrier sequence, the carrier sequence comprising, in a 5' to 3' direction, a positioning sequence and a first immobilization sequence; the positioning sequence has a unique nucleotide sequence that corresponds to the location of the type of carrier sequence in the array; The first immobilized sequence is capable of annealing to its complementary nucleotide sequence and inducing an extension reaction; Nucleic acid arrays.

2. a first nucleic acid molecule, the first nucleic acid molecule comprising, in a 5' to 3' direction, a complement of the first immobilized sequence and a complement of the positioning sequence, the first nucleic acid molecule hybridizing to the first immobilized sequence and the positioning sequence of the carrier sequence to form a duplex; Preferably, each copy of each type of carrier sequence comprises a first nucleic acid molecule hybridized to said copy, The nucleic acid array of claim 1.

3. further comprising a second nucleic acid molecule, said second nucleic acid molecule being ligated to said first nucleic acid molecule, said second nucleic acid molecule comprising a capture sequence; the capture sequence is capable of hybridizing to all or a portion of the nucleic acid to be captured and comprises (a) an oligonucleotide sequence capable of capturing mRNA; and / or (b) a random or degenerate oligonucleotide sequence; or (c) a sequence specific to a particular target nucleic acid; the capture sequence has a free 3' end to allow the second nucleic acid molecule to function as an extension primer; Preferably, each first nucleic acid molecule is ligated to said second nucleic acid molecule. A nucleic acid array according to claim 1 or 2.

4. each carrier sequence further comprising a second immobilized sequence at its 5' end, said second immobilized sequence capable of annealing to its complementary nucleotide sequence; The second immobilized sequence is capable of annealing to its complementary nucleotide sequence and inducing an extension reaction. A nucleic acid array according to claim 1 or 2.

5. a second nucleic acid molecule, the second nucleic acid molecule comprising, in a 5' to 3' direction, a complement of the second immobilized sequence and a capture sequence; the complement of the second immobilized sequence hybridizes to the second immobilized sequence of the carrier sequence to form a duplex; the capture sequence is capable of hybridizing to all or a portion of the nucleic acid to be captured and comprises (a) an oligonucleotide sequence capable of capturing mRNA; and / or (b) a random or degenerate oligonucleotide sequence; or (c) a sequence specific to a particular target nucleic acid; the capture sequence has a free 3' end to allow the second nucleic acid molecule to function as an extension primer; Preferably, each copy of each type of carrier sequence comprises a second nucleic acid molecule hybridized to said copy, The nucleic acid array of claim 4.

6. the multiple copies of the carrier sequence are amplification products formed by amplification using a complementary sequence of the carrier sequence as a template, the amplification being selected from rolling circle amplification (RCA), bridge PCR amplification, multiple strand displacement amplification (MDA), or emulsion PCR amplification; Preferably, the multiple copies of the carrier sequence are DNBs formed by concatemerization of the carrier sequence; preferably, the multiple copies of the carrier sequence are DNBs formed by rolling circle amplification using complementary sequences of the carrier sequence as templates; Preferably, said multiple copies of a carrier sequence are DNA clusters formed by a clonal population of said carrier sequences; For example, the multiple copies of a carrier sequence are DNA clusters formed by bridge PCR amplification using a complementary sequence of the carrier sequence as a template; For example, the multiple copies of a carrier sequence are DNA clusters formed by emulsion PCR amplification using complementary sequences of the carrier sequence as templates; For example, the multiple copies of a carrier sequence are DNA clusters formed by multiple strand displacement amplification using complementary sequences of the carrier sequence as templates. The nucleic acid array according to any one of claims 1 to 5.

7. the first nucleic acid molecule further comprises a unique molecular identifier (UMI) sequence, the UMI sequence being located at a 5' end of the complement of the first immobilized sequence; the UMI sequence is a nucleotide sequence consisting of at least one (e.g., at least two, at least three, at least four, or at least five; e.g., 5-100) nucleotides N, where each N is independently any one of A, C, G, and T; Preferably, the UMI sequences contained in each first nucleic acid molecule are different from each other. The nucleic acid array according to any one of claims 1 to 6.

8. the second nucleic acid molecule further comprises a UMI sequence, the UMI sequence being located at a 5' end of the capture sequence; the UMI sequence is a nucleotide sequence consisting of at least one (e.g., at least two, at least three, at least four, or at least five; e.g., 5-100) nucleotides N, where each N is independently any one of A, C, G, and T; Preferably, the UMI sequences contained in each second nucleic acid molecule are different from each other. The nucleic acid array according to any one of claims 1 to 6.

9. the solid support is a chip; Preferably, the solid support may be used as a sequencing platform, such as a sequencing chip; Preferably, the solid support is a high-throughput sequencing chip, such as a high-throughput sequencing chip used in an Illumina, MGI, or Thermo Fisher sequencing platform; The nucleic acid array according to any one of claims 1 to 8.

10. the oligonucleotide sequence capable of capturing an mRNA comprises a sequence capable of hybridizing to the poly A tail of the mRNA; Preferably, said oligonucleotide sequence capable of capturing mRNA comprises a poly-T oligonucleotide sequence; Preferably, the poly-T oligonucleotide sequence comprises at least 10 (e.g., at least 20) deoxythymidine residues. The nucleic acid array according to any one of claims 1 to 9.

11. the carrier sequence further comprises a capture sequence template located upstream of the positioning sequence, the capture sequence template comprising a complementary sequence of the capture sequence, the capture sequence being capable of hybridizing to all or a portion of a nucleic acid to be captured and comprising (a) an oligonucleotide sequence capable of capturing mRNA; and / or (b) a random or degenerate oligonucleotide sequence; or (c) a sequence specific for a particular target nucleic acid; The first immobilized sequence of the carrier sequence may also comprise a cleavage site, and the cleavage may be selected from enzymatic cleavage with a nicking enzyme, enzymatic cleavage with a USER enzyme, photocleavage, chemical cleavage, or CRISPR-based cleavage; The nucleic acid array further comprises a first nucleic acid molecule, the first nucleic acid molecule comprising, in a 5' to 3' direction, a binding region, a cleavage region, and a region of complementarity to a carrier sequence; the binding region comprises a linker capable of ligating to the surface of the solid support; the cleavage region comprises a cleavage site; the complementary region of the carrier sequence comprises a sequence that can be complementary to the carrier sequence and includes, in a 5' to 3' direction, a complement of the first immobilized sequence, a complement of the positioning sequence, and a capture sequence; the capture sequence has a free 3' end to allow the first nucleic acid molecule to function as an extension primer; a complementary region of the carrier sequence of the first nucleic acid molecule hybridizes with the carrier sequence to form a duplex; Preferably, each copy of each type of carrier sequence comprises a first nucleic acid molecule hybridized to said copy, The nucleic acid array of claim 1.

12. the carrier sequence further comprises a complement of a UMI sequence disposed downstream of the capture sequence template and upstream of the first immobilized sequence, the complement of the UMI sequence being complementary to the UMI sequence, the UMI sequence being a nucleotide sequence consisting of at least one (e.g., at least two, at least three, at least four, or at least five; e.g., between 5 and 100) nucleotides N, each N being independently any one of A, C, G, and T; the complementary region of the carrier sequence of the first nucleic acid molecule further comprises a UMI sequence located upstream of the capture sequence and downstream of the complement of the first immobilized sequence; Preferably, the complement of the UMI sequence is located between the positioning sequence and the capture sequence template, or between the first immobilized sequence and the positioning sequence; Preferably, each copy of each type of carrier sequence (i.e., carrier sequences containing the same positioning sequence) contains a complement of a UMI sequence that is different from each other. The nucleic acid array of claim 11.

13. The linker of the first nucleic acid molecule is an activating group (e.g., NH 2 ), and the surface of the solid support is a linking group capable of coupling to the activating group (e.g., NH 2 ) modified by; Preferably, the linker comprises -SH, -DBCO, or -NHS; Preferably, the linker is 【Chemistry 1】 and 【Chemistry 2】 is attached to the surface of the solid support; A nucleic acid array according to claim 11 or 12.

14. the cleavage site contained in the cleavage region of the first nucleic acid molecule is a site at which controlled cleavage can be performed by chemical, enzymatic, or photochemical methods; Preferably, the cleavage site contained in the cleavage region of the first nucleic acid molecule is an enzymatic cleavage site; Preferably, the cleavage region of the first nucleic acid molecule is different from the cleavage site contained in the first immobilized sequence of the carrier sequence. The nucleic acid array according to any one of claims 11 to 13.

15. the solid support is a chip; Preferably, the solid support may be used as a sequencing platform, such as a sequencing chip; Preferably, the solid support is a high-throughput sequencing chip, such as a high-throughput sequencing chip used in an Illumina, MGI, or Thermo Fisher sequencing platform; The nucleic acid array according to any one of claims 11 to 14.

16. the oligonucleotide sequence capable of capturing an mRNA comprises a sequence capable of hybridizing to the poly A tail of the mRNA; Preferably, said oligonucleotide sequence capable of capturing mRNA comprises a poly-T oligonucleotide sequence; Preferably, the poly-T oligonucleotide sequence comprises at least 10 (e.g., at least 20) deoxythymidine residues. The nucleic acid array according to any one of claims 11 to 15.

17. (i) a nucleic acid array according to any one of claims 1 to 10, which does not comprise a second nucleic acid molecule; and (ii) a second nucleic acid molecule comprising, in the 5' to 3' direction, an immobilization region and a capture sequence; the capture sequence is capable of hybridizing to all or a portion of the nucleic acid to be captured and comprises (a) an oligonucleotide sequence capable of capturing mRNA; and / or (b) a random or degenerate oligonucleotide sequence; or (c) a sequence specific to a particular target nucleic acid; and the capture sequence has a free 3' end to allow the second nucleic acid molecule to function as an extension primer. kit.

18. 16. The kit of claim 15, comprising the nucleic acid array of claim 2, wherein the immobilization region of the second nucleic acid molecule comprises a double-stranded nucleic acid sequence (e.g., a double-stranded DNA sequence).

19. 16. The kit of claim 15, comprising the nucleic acid array of claim 4, wherein the immobilized region of the second nucleic acid molecule comprises the complement of a second immobilized sequence.

20. When the first nucleic acid molecule contained in the nucleic acid array does not contain a UMI sequence, the second nucleic acid molecule further contains a UMI sequence, and the UMI sequence is located at the 5' end of the capture sequence; the UMI sequence is a nucleotide sequence consisting of at least one (e.g., at least two, at least three, at least four, or at least five; e.g., 5-100) nucleotides N, where each N is independently any one of A, C, G, and T; The kit according to any one of claims 15 to 17.

21. 1. A method for producing a nucleic acid array for detecting spatial information of a nucleic acid in a biological sample, comprising the steps of: (1) providing a plurality of types of carrier sequences, each type of carrier sequence comprising a plurality of copies of the carrier sequence, the carrier sequence comprising, in a 5' to 3' direction, a positioning sequence, and a first immobilization sequence; the positioning sequence has a unique nucleotide sequence that corresponds to the location of the type of carrier sequence in the array; allowing the first immobilized sequence to anneal to its complementary nucleotide sequence and trigger an extension reaction; (2) ligating the multiple types of carrier sequences to the surface of a solid support (e.g., a chip); (3) preparing a first primer and performing a primer extension reaction by using the carrier sequence as a template such that the region of the first immobilized sequence and the positioning sequence of the carrier sequence form a double strand, the strand hybridizing with the carrier sequence being a first nucleic acid molecule, the first nucleic acid molecule comprising, in a 5' to 3' direction, the first immobilized sequence and a complementary sequence of the positioning sequence; the first primer comprising, at its 3' end, a complementary region of the first immobilized sequence, the complementary region of the first immobilized sequence comprising the complementary sequence of the first immobilized sequence or a fragment thereof, and having a free 3' end; The method includes:

22. In step (1), the plurality of types of carrier sequences are subjected to the following steps: (i) preparing a plurality of types of carrier sequence templates, the carrier sequence templates including complementary sequences of the carrier sequences; (ii) performing a nucleic acid amplification reaction by using each type of carrier sequence template as a template to obtain an amplification product of each type of carrier sequence template, wherein the amplification product comprises multiple copies of the carrier sequence; Preferably, the amplification is selected from rolling circle amplification (RCA), bridge PCR amplification, multiple strand displacement amplification (MDA), or emulsion PCR amplification; Preferably, rolling circle amplification is carried out to obtain DNBs formed by concatemers of said carrier sequences; Preferably, bridge PCR amplification, emulsion PCR amplification, or multiple strand displacement amplification is performed to obtain DNA formed by a clonal population of said carrier sequences.

22. The method of claim 21 , provided by:

23. Steps below: (4) providing a second nucleic acid molecule, the second nucleic acid molecule comprising a capture sequence; the capture sequence is capable of hybridizing to all or a portion of the nucleic acid to be captured and comprises (a) an oligonucleotide sequence capable of capturing mRNA; and / or (b) a random or degenerate oligonucleotide sequence; or (c) a sequence specific to a particular target nucleic acid; the capture sequence having a free 3' end to allow the second nucleic acid molecule to function as an extension primer; (5) ligating the second nucleic acid molecule to the first nucleic acid molecule (e.g., using a ligase to ligate the second nucleic acid molecule to the first nucleic acid molecule).

23. The method of claim 21 or 22, further comprising:

24. 24. The method of claim 23, wherein the second nucleic acid molecule comprises, in a 5' to 3' direction, an immobilization region and a capture sequence, the immobilization region comprising a double-stranded DNA sequence.

25. Each carrier sequence further comprises at its 5' end a second immobilized sequence, said second immobilized sequence being capable of annealing to its complementary nucleotide sequence; (4) providing a second nucleic acid molecule, the second nucleic acid molecule comprising, in a 5' to 3' direction, a complement of the second immobilized sequence and a capture sequence; allowing the complement of the second immobilized sequence to hybridize with its complementary nucleotide sequence; the capture sequence is capable of hybridizing to all or a portion of the nucleic acid to be captured and comprises (a) an oligonucleotide sequence capable of capturing mRNA; and / or (b) a random or degenerate oligonucleotide sequence; or (c) a sequence specific to a particular target nucleic acid; the capture sequence having a free 3' end to allow the second nucleic acid molecule to function as an extension primer; (5) hybridizing the complement of the second immobilized sequence to the second immobilized sequence under conditions that allow annealing, thereby ligating the second nucleic acid molecule to the carrier sequence; (6) Optionally, ligating the first and second nucleic acid molecules, each of which is hybridized to the carrier sequence (e.g., ligating the second nucleic acid molecule to the first nucleic acid molecule using a ligase).

24. The method of claim 23, further comprising:

26. In step (3), the first primer further comprises a UMI (unique molecular identifier) ​​at the 5' end of the complementary region of the first immobilized sequence, such that the first nucleic acid molecule comprises the UMI sequence at the 5' end of the complement of the first immobilized sequence; or in step (4), the second nucleic acid molecule further comprises a UMI sequence, the UMI sequence being located at the 5' end of the capture sequence; the UMI sequence is a nucleotide sequence consisting of at least one (e.g., at least two, at least three, at least four, or at least five; e.g., 5-100) nucleotides N, where each N is independently any one of A, C, G, and T; 26. The method according to any one of claims 23 to 25.

27. In step (1), the carrier sequence further comprises a capture sequence template located upstream of the positioning sequence, the capture sequence template comprising a complementary sequence of the capture sequence, the capture sequence being capable of hybridizing with all or a portion of the nucleic acid to be captured, and comprising (a) an oligonucleotide sequence capable of capturing mRNA; and / or (b) a random or degenerate oligonucleotide sequence; or (c) a sequence specific to a particular target nucleic acid; the first immobilized sequence of the carrier sequence may also comprise a cleavage site, the cleavage being selected from enzymatic cleavage by a nicking enzyme, enzymatic cleavage by a USER enzyme, photocleavage, chemical cleavage, or CRISPR-based cleavage; In step (3), the first immobilized sequence, the positioning sequence, and the capture sequence template regions of the carrier sequence are double-stranded such that the first nucleic acid molecule comprises, in a 5' to 3' direction, a complement of the first immobilized sequence, a complement of the positioning sequence, and a capture sequence; the first primer comprises, in a 5' to 3' direction, a binding region, a cleavage region, and a region of complementarity to a first immobilized sequence, the binding region comprising a linker capable of ligating to a surface of the solid support, and the cleavage region comprising a cleavage site; The method comprises the steps of: (4) ligating the first primer to the surface of the solid support, wherein steps (3) and (4) are performed in any order; (5) Optionally, performing cleavage at the cleavage site contained in the first immobilized sequence of the carrier sequence to digest the carrier sequence, such that the extension product in step (3) is separated from the template (i.e., carrier sequence) on which such extension product is formed, thereby ligating the first nucleic acid molecule to the surface of the solid support (e.g., chip). Further comprising: Preferably, each type of carrier sequence is a DNB formed by a concatemer of said multiple copies of the carrier sequence; 23. The method of claim 22.

28. In step (1), the cleavage site contained in the first immobilization sequence is a cleavage site for a nicking enzyme; Preferably, the nicking enzyme is selected from USER, BamHI, and BmtI.

28. The method of claim 27.

29. In step (1), the carrier sequence further comprises a complement of a UMI sequence disposed downstream of the capture sequence template and upstream of the first immobilized sequence, the complement of the UMI sequence being complementary to a UMI sequence, the UMI sequence being a nucleotide sequence consisting of at least one (e.g., at least two, at least three, at least four, or at least five; e.g., 5-100) nucleotide N, each N being independently any one of A, C, G, and T; In step (3), the first immobilized sequence, the positioning sequence, the capture sequence template, and the region of the complement of the UMI sequence of the carrier sequence form a double strand, such that the first nucleic acid molecule comprises, in a 5' to 3' direction, the complement of the first immobilized sequence, the complement of the positioning sequence, and the capture sequence, and a UMI sequence disposed upstream of the capture sequence and downstream of the complement of the first immobilized sequence; Preferably, the complement of the UMI sequence is located between the positioning sequence and the capture sequence template, or between the first immobilized sequence and the positioning sequence.

29. The method of claim 27 or 28.

30. The linker of the first primer has an activating group (e.g., NH 2 ), and the surface of the solid support is a linking group capable of coupling to the activating group (e.g., NH 2 ) modified by; Preferably, the linker comprises -SH, -DBCO, or -NHS; Preferably, the linker is 【Chemistry 3】 and 【Chemistry 4】 is attached to the surface of the solid support; 30. The method according to any one of claims 27 to 29.

31. the cleavage site contained in the cleavage region of the first primer is a site at which controlled cleavage can be performed by chemical, enzymatic, or photochemical methods; Preferably, the cleavage site contained in the cleavage region of the first primer is an enzymatic cleavage site; Preferably, the cleavage region of the first primer is different from the cleavage site contained in the first immobilization sequence of the carrier sequence; The method according to any one of claims 27 to 30.

32. the oligonucleotide sequence capable of capturing an mRNA comprises a sequence capable of hybridizing to the poly A tail of the mRNA; Preferably, said oligonucleotide sequence capable of capturing mRNA comprises a poly-T oligonucleotide sequence; Preferably, the poly-T oligonucleotide sequence comprises at least 10 (e.g., at least 20) deoxythymidine residues.

32. The method according to any one of claims 21 to 31.

33. the solid support is a chip; Preferably, the solid support may be used as a sequencing platform, such as a sequencing chip; Preferably, the solid support is a high-throughput sequencing chip, such as a high-throughput sequencing chip used in an Illumina, MGI, or Thermo Fisher sequencing platform; 33. The method according to any one of claims 21 to 32.

34. The method according to any one of claims 21 to 33, wherein in step (3), the carrier sequence is sequenced to obtain sequence information of the positioning sequence contained in the carrier sequence during the extension reaction.

35. Prior to step (3), a step of sequencing the carrier sequence is included; Preferably, after the sequencing is completed, washing is performed to remove dNTPs added to the synthetic strand for the sequencing.

35. The method according to any one of claims 21 to 34.

36. Preferably, the nucleic acid array is as defined in any one of claims 3 and 5 to 10. A nucleic acid array prepared by the method according to any one of claims 23 to 26.

37. Preferably, the nucleic acid array is as defined in any one of claims 11 to 16. A nucleic acid array prepared by the method according to any one of claims 27 to 31.

38. 1. A method for detecting spatial information of a nucleic acid in a sample, comprising the steps of: (1) preparing a nucleic acid array according to claim 3 or 5, or obtaining a nucleic acid array according to a method according to any one of claims 23 to 26, the nucleic acid array comprises a plurality of types of carrier sequences attached to a surface of a solid support (e.g., a chip), each type of carrier sequence occupies a different location in the array, and each type of carrier sequence comprises multiple copies of the carrier sequence; each carrier sequence comprises a first nucleic acid molecule hybridized to said respective carrier sequence, and said first nucleic acid molecule is ligated to a second nucleic acid molecule, or each carrier sequence comprises a first nucleic acid molecule and a second nucleic acid molecule hybridized to said respective carrier sequence; the first nucleic acid molecule comprises a complement of a positioning sequence that corresponds to the location of the type of carrier sequence in the array; the second nucleic acid molecule comprises a capture sequence capable of capturing the nucleic acid in the sample; (2) contacting the nucleic acid array with the test sample under conditions that allow the nucleic acid in the test sample to anneal to the capture sequence of the second nucleic acid molecule, such that the location of the nucleic acid can be correlated with the location of the carrier sequence on the nucleic acid array; (3)(i) ligating (e.g., using a ligase) the first and second nucleic acid molecules, which are hybridized to respective carrier sequences, if the first and second nucleic acid molecules are not ligated to each other; performing a primer extension reaction by using the ligated first and second nucleic acid molecules as primers and using the captured nucleic acid molecule as a template under conditions allowing the primer extension to provide an extension product, the strand which hybridizes to the captured nucleic acid molecule having as a spatial information tag the complement of the positioning sequence contained in the first nucleic acid molecule; and / or performing a primer extension reaction by using the captured nucleic acid molecule as a primer and using the ligated first and second nucleic acid molecules as templates under conditions allowing for the primer extension to result in a captured and extended nucleic acid molecule, the captured and extended nucleic acid having the positioning sequence as a spatial information tag; Alternatively, (ii) performing a primer extension reaction by using the second nucleic acid molecule as a primer and the captured nucleic acid molecule as a template under conditions that allow the primer extension when the first and second nucleic acid molecules are not ligated to each other, resulting in an extended second nucleic acid molecule, the extended second nucleic acid molecule comprising a complementary sequence of the captured nucleic acid; ligating (e.g., using a ligase) the first nucleic acid molecule and the extended second nucleic acid molecule that are hybridized to respective carrier sequences, the extended second nucleic acid molecule that is ligated to the first nucleic acid molecule having as a spatial information tag the complement of the positioning sequence contained in the first nucleic acid molecule; Alternatively, (iii) performing a primer extension reaction by using the ligated first and second nucleic acid molecules as primers and using the captured nucleic acid molecule as a template under conditions that allow the primer extension when the first and second nucleic acid molecules are ligated to each other, to provide an extension product, wherein the strand that hybridizes to the captured nucleic acid molecule has the complement of the positioning sequence contained in the first nucleic acid molecule as a spatial information tag; and / or performing a primer extension reaction by using the captured nucleic acid molecule as a primer and using the ligated, connected first and second nucleic acid molecules as templates under conditions allowing for the primer extension to result in a captured, extended nucleic acid molecule, the captured, extended nucleic acid molecule having the positioning sequence as a spatial information tag; (4) releasing at least a portion of the nucleic acid molecules labeled with spatial information tags from the surface of the array, the portion including the positioning sequence or its complementary strand and the captured nucleic acid molecule or its complementary strand; and (5) directly or indirectly analyzing the sequence of the nucleic acid molecules released in step (4); Preferably, the spatial information of the nucleic acid comprises the location, distribution, and / or expression of the nucleic acid; Preferably, the sample is a tissue sample, such as a tissue section; Preferably, the tissue sections are prepared from fixed tissue, e.g., formalin-fixed paraffin-embedded (FFPE) tissue, or flash-frozen tissue. Steps The method includes:

39. used to detect the transcriptome in a sample, (a) in step (3)(i), a cDNA molecule is generated from the captured RNA molecule by using the ligated first and second nucleic acid molecules as reverse transcription primers, the cDNA molecule having a complement of the positioning sequence contained in the first nucleic acid molecule as a spatial information tag, and optionally the cDNA molecule is amplified; or in step (3)(ii), a cDNA molecule is generated from the captured RNA molecule by using the second nucleic acid molecule as a reverse transcription primer, the cDNA molecule having a complement of the positioning sequence contained in the first nucleic acid molecule as a spatial information tag, and optionally the cDNA molecule is amplified. ligating the first nucleic acid molecule and the cDNA molecule hybridizing to each carrier sequence (e.g., by using a ligase) to generate a cDNA molecule having a complement, and optionally amplifying the cDNA molecule; or in step (3)(iii), generating a cDNA molecule from the captured RNA molecule by using the ligated first and second nucleic acid molecules as reverse transcription primers, the cDNA molecule having a complement of the positioning sequence contained in the first nucleic acid molecule as a spatial information tag, and optionally amplifying the cDNA molecule; (b) in step (4), at least a portion of the cDNA molecules and / or their amplicons are released from the surface of the array, the released nucleic acid molecules may be first and / or second strands of the cDNA molecules or their amplicons, the portion comprising the positioning sequence or its complementary strand; Preferably, in step (1), the capture sequence comprises an oligonucleotide sequence capable of capturing mRNA; 39. The method of claim 38.

40. 1. A method for detecting spatial information of a nucleic acid in a sample, comprising the steps of: (1) Providing a nucleic acid array according to any one of claims 11 to 16 or obtaining a nucleic acid array by the method according to any one of claims 27 to 31, the nucleic acid array comprising a solid support (e.g. a chip) having a plurality of types of carrier sequences attached to its surface, each type of carrier sequence occupying a different position in the array, each type of carrier sequence comprising a plurality of copies of the carrier sequence; Each carrier sequence comprises a first nucleic acid molecule hybridized to said respective carrier sequence, said first nucleic acid molecule comprising a complement of a positioning sequence corresponding to the position of said type of carrier sequence in said array, and a capture sequence capable of capturing said nucleic acid in said sample. Steps: (2) contacting the nucleic acid array with the test sample under conditions that allow the nucleic acid in the test sample to anneal to the capture sequence of the first nucleic acid molecule, such that the location of the nucleic acid can be correlated with the location of the first nucleic acid molecule on the nucleic acid array; (3) performing a primer extension reaction by using the first nucleic acid molecule as a primer and the captured nucleic acid molecule as a template under conditions allowing the primer extension to result in an extension product, wherein the strand that hybridizes with the captured nucleic acid molecule has the complement of the positioning sequence contained in the first nucleic acid molecule as a spatial information tag; (4) releasing at least a portion of the nucleic acid molecules labeled with the spatial information tag from the surface of the array, the portion including the positioning sequence or its complementary strand and the captured nucleic acid molecule or its complementary strand; and (5) directly or indirectly analyzing the sequence of the nucleic acid molecules released in step (4); Preferably, the spatial information of the nucleic acid comprises the location, distribution, and / or expression of the nucleic acid; Preferably, the sample is a tissue sample, such as a tissue section; Preferably, the tissue sections are prepared from fixed tissue, e.g., formalin-fixed paraffin-embedded (FFPE) tissue, or flash-frozen tissue. Steps The method includes:

41. used to detect the transcriptome in a sample, In step (3), a cDNA molecule is generated from the captured RNA molecule by using the first nucleic acid molecule as an RT primer, the cDNA molecule having a complement of the positioning sequence contained in the first nucleic acid molecule as a spatial information tag, and optionally the cDNA molecule is amplified; In step (4), at least a portion of the cDNA molecules and / or their amplicons are released from the surface of the array, the released nucleic acid molecules can be first and / or second strands of the cDNA molecules or their amplicons, the portion comprising the positioning sequence or its complementary strand; Preferably, in step (1), the capture sequence comprises an oligonucleotide sequence capable of capturing mRNA.

41. The method of claim 40.

42. The multiple copies of the carrier sequence are DNA clusters formed by a clonal population of the carrier sequence, or the multiple copies of the carrier sequence are DNA clusters formed by a clonal population of the carrier sequence.

42. The method according to any one of claims 38 to 41.

43. The method according to any one of claims 38 to 42, wherein in step (5), the sequence analysis comprises sequencing or a sequence-specific PCR reaction.

44. Step (6): Correlating the sequence analysis information obtained in step (5) with an image of the sample, the sample being imaged before or after step (3); Preferably, imaging of the sample is performed using optical microscopy, bright field microscopy, dark field microscopy, phase contrast microscopy, fluorescence microscopy, reflected light microscopy, interference microscopy, confocal microscopy, or a combination thereof.

44. The method according to any one of claims 38 to 43.

45. providing a complementary or second strand of cDNA before or after the nucleic acid molecules (e.g., DNA molecules) labeled with a spatial information tag or the cDNA molecules labeled with a spatial information tag are released from the surface of the array; Preferably, the synthesis of the complementary strand or the second strand uses random primers and a strand-displacing polymerase.

45. The method according to any one of claims 38 to 44.

46. The method further comprises the step of amplifying the nucleic acid molecules (e.g., DNA molecules) or cDNA molecules labeled with the spatial information tags prior to sequence analysis; Preferably, the amplification step is performed after the nucleic acid molecules (e.g., DNA molecules) or cDNA molecules labeled with the spatial information tag are released from the array, or the amplification step is performed in situ on the array; Preferably, the amplification step comprises PCR.

46. ​​The method according to any one of claims 38 to 45.

47. The method of any one of claims 38 to 46, further comprising the step of purifying the released nucleic acid molecules prior to sequence analysis.

48. The method of any one of claims 38 to 47, further comprising the step of washing the array to remove any residue of the sample (eg, tissue) prior to step (4).

49. The method of any one of claims 38 to 48, wherein in step (4), the nucleic acid molecules are released from the surface of the array by the following methods: (i) a nucleic acid cleavage method; (ii) a nucleic acid denaturation method; and / or (iii) a physical method.